The Influence of Clinically Meaningful Factors on the Performance of the Recommended Annual Diabetic Foot Screening by Sando, Trisha A
Virginia Commonwealth University 
VCU Scholars Compass 
Theses and Dissertations Graduate School 
2018 
The Influence of Clinically Meaningful Factors on the 
Performance of the Recommended Annual Diabetic Foot 
Screening 
Trisha A. Sando 
Virginia Commonwealth University 
Follow this and additional works at: https://scholarscompass.vcu.edu/etd 
 Part of the Clinical Epidemiology Commons 
 
© The Author 
Downloaded from 
https://scholarscompass.vcu.edu/etd/5323 
This Dissertation is brought to you for free and open access by the Graduate School at VCU Scholars Compass. It 
has been accepted for inclusion in Theses and Dissertations by an authorized administrator of VCU Scholars 
Compass. For more information, please contact libcompass@vcu.edu. 
1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
© Trisha A. Sando, DPT, CWS, MSc     2018 
All Rights Reserved 
 
 
i 
 
 
 
 
 
 
 
 
 
 
The Influence of Clinically Meaningful Factors on the Performance of the 
Recommended Annual Diabetic Foot Screening 
 
 
A dissertation submitted in partial fulfillment of the requirements for the degrees of Doctor of 
Philosophy at Virginia Commonwealth University 
 
 
 
 
 
By: 
 
Trisha Arlene Sando, Ph.D, DPT, CWS, MSc 
Bachelors of Science in Biology, California Institute of Technology, 2001 
Doctor of Physical Therapy, University of Southern California, 2005 
Masters of Science in Wound Healing and Tissue Repair, Cardiff University, 2015 
 
 
Director:  
 
Juan Lu, Ph.D., MPH, MD 
Associate Professor 
Division of Epidemiology, Department of Family Medicine and Population Health 
Virginia Commonwealth University 
 
 
 
 
 
 
 
Virginia Commonwealth University 
Richmond, Virginia 
April, 2018  
 
  
ii 
 
 
 
 
 
 
 
Acknowledgements 
 
 
 
 
 The author wishes to thank several people for their support throughout the writing of this 
dissertation process.  I would like to thank the members of my dissertation committee: Dr. Juan 
Lu, Dr. Steven A. Cohen, Dr. Robert Perera and Dr. Edmond Trey Wickham for their guidance 
throughout this project.  I would like to thank the Department of Family Medicine and 
Population Health, Division of Epidemiology for their support.  Thank you also to Dr. Daniel 
Provenzano who assisted in generating the figures present in Chapters 4 and 5 of this 
dissertation.  I would like to thank my parents, Mr. Stewart Sando and Mrs. Patricia Sando, my 
sisters Mrs. Renee Pearl and Mrs. Rebecca Gunning for all of their support during my many 
academic pursuits including the writing of this dissertation project.    
 
 
  
iii 
 
 
 
 
Table of Contents 
 
 
List of Tables and Figures…………………………………………………………………………v 
List of Abbreviations……………………………………………………………………………..vi 
Abstract……………………………………………………………………………………………1 
CHAPTER 1: Background………………………………………………………………………...3 
CHAPTER 2: Description of the dataset………………………………………………………...14 
CHAPTER 3:  Are diabetes mellitus self-care behaviors associated with the receipt  
of the recommended annual diabetes foot screening examination?...............................................17 
 Abstract…………………………………………………………………………………..18 
 Introduction………………………………………………………………………………20 
 Research design and methods……………………………………………………………21 
 Results……………………………………………………………………………………26 
 Conclusions………………………………………………………………………………34 
CHAPTER 4:  The association between comorbidities and the performance  
of the recommended annual diabetes foot screening examination………………………………38 
Abstract…………………………………………………………………………………..39 
 Introduction………………………………………………………………………………40 
 Research design and methods……………………………………………………………43 
iv 
 
 Results……………………………………………………………………………………48 
 Conclusions………………………………………………………………………………54 
CHAPTER 5:  The association between visit frequency and competing demands on the  
performance of the recommended annual clinical diabetic foot screening………………………59 
Abstract…………………………………………………………………………………..60 
 Introduction………………………………………………………………………………61 
 Research design and methods……………………………………………………………62 
 Results……………………………………………………………………………………66 
 Conclusions………………………………………………………………………………72 
CHAPTER 6: Summary………………………………………………………………………….76 
CHAPTER 7: References………………………………………………………………………..84 
Vita……………………………………………………………………………………………….94 
 
 
  
v 
 
 
 
 
List of Tables and Figures 
 
 
 
Table 1-1.  Recommended diabetes self-management behaviors and reported  
rates of adherence………………………………………………………………………..10 
Table 3-1.  Characteristics of persons aged >18 years with diagnosed diabetes,  
38 states (n=14,823)……………………………………………………………………...27 
Table 3-2.  Reported performance of recommended diabetes mellitus  
self-management behaviors in persons aged ≥18 years with diagnosed  
diabetes, 38 states (n=14,823)……………………………………………………………30 
Table 3-3.  Multiple Logistic Regression Model Estimates of Odds Ratios  
(OR) and 95% CI for the association between patient performance  
of 8 individual diabetes mellitus self-care behaviors on the  
performance of the recommended annual diabetes foot screening  
examination (n=14,823)………………………………………………………………….32 
Table 3-4.  Multiple logistic regression model estimates of odds ratios  
(OR) and 95% CI to assess for outcome non-response bias in  
estimates for the influence of patient performance of 8 individual  
diabetes mellitus self-management behaviors on the performance  
of the recommended annual diabetes foot screening examination………………………34 
Table 4-1.  Recommended diabetes preventive care processes and  
Healthy People 2020 reported results……………………………………………………41 
Table 4-2.  Demographic characteristics of persons aged ≥18 years with  
diagnosed diabetes, 38 states (n=20,882)………………………………………………..49 
Table 4-3.  Reported comorbid conditions in persons aged ≥18 years with  
diagnosed diabetes, 38 states (n=20,882)………………………………………………..51 
Table 4-4.  Unstandardized coefficients, standardized coefficients and  
percentage of variance explained for the final CFA model……………………………...53 
Figure 4-1.  Final SEM model…………………………………………………………………...54 
Table 4-5.  Unstandardized estimates (β), standard error (SE) and p-values  
for regression pathways of the final SEM model………………………………………...54 
Table 5-1.  Demographic characteristics of persons aged ≥18 years with  
diagnosed diabetes, 38 states (n=19,056)………………………………………………..67 
Table 5-2.  Reported completion of diabetes preventive care processes in  
persons aged ≥18 years with diagnosed diabetes, 38 states (n=19,056)…………………69 
Table 5-3.  Final CFA model unstandardized coefficients, standardized  
coefficients and percentage of variance explained for each indicator…………………...71 
Figure 5-1.  Final SEM model…………………………………………………………………...71 
vi 
 
Table 5-4.  Odds ratios (OR), 95% confidence intervals (95% CI)) and  
p-values for regression pathways of the final SEM model………………………………72 
 
  
vii 
 
 
 
 
List of Abbreviations 
 
 
 
ADA- American Diabetes Association 
ADFSE- annual diabetes foot screening examination 
BRFSS- Behavioral Risk Factor Surveillance System 
CAD- coronary artery disease 
CDC- Centers for Disease Control and Prevention 
CFA- confirmatory factor analysis 
CFI- comparative fit index 
CMS- Centers for Medicare and Medicaid Services 
COPD- Chronic obstructive pulmonary disease 
CVA- cerebrovascular accident 
DFU- diabetic foot ulcer 
EMR- electronic medical record 
HgbA1c- glycosylated hemoglobin/hemoglobin A1c 
IWGDF- International Working Group on the Diabetic Foot 
LEA- lower extremity amputation 
MEPS- Medical Expenditures Panel Survey 
MI- myocardial infarction 
PCMH- patient centered medical home 
PN- peripheral neuropathy 
PQRI- Physicians Quality Reporting Initiative 
PQRS- Physicians Quality Reporting System 
PVD- peripheral vascular disease 
RMSEA- root mean squared error of approximation 
SEM- structural equation modeling 
SMBG- self-monitoring blood glucose 
T1DM- type 1 diabetes mellitus 
T2DM- type 2 diabetes mellitus 
VHA- Veterans Health Administration 
 
1 
 
 
 
Abstract 
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Background: Diabetic foot ulcers are the result of multiple complications from hyperglycemia 
and lead to poor quality of life and high healthcare costs.  The annual diabetes foot screening 
exam (ADFSE) and prevention interventions can reduce DFUs up to 75%.  In 2015, 71% of the 
US population received the ADFSE.   
Objectives:  The main objectives of this dissertation were: 1) to determine the association 
between adherence to diabetes self-management behaviors and the ADFSE, 2) to determine the 
association between concordant and discordant comorbidities and the ADFSE and 3) to 
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determine the association between the performance of diabetes preventive care processes, 
number of office visits for diabetes and the completion of the ADFSE. 
Methods: Three cross-sectional studies used data from the 2015 Behavioral Risk Factor 
Surveillance System.  Logistic regression models were evaluated to assess the association 
between the self-management behaviors and the ADFSE.  Structural equation modeling (SEM) 
was used to assess the simultaneous, direct effects of concordant and discordant comorbidity 
loads on the ADFSE and the performance of diabetes preventive care processes and the number 
of office visits for diabetes care on the ADFSE.     
Results: In 2015, between 78.2% and 80.4% of the US population with diabetes received the 
ADFSE.   Performance of the ADFSE was 77% less likely (OR: 0.33, 95%CI: 0.25-0.44) in 
those who do not perform self-foot inspections and 40% (OR: 0.59, 95%CI: 0.45-0.76) less 
likely in those who have never received the pneumococcal vaccination.  Receiving the ADFSE 
was 50-80% less likely in patients who do not self-monitor blood glucose at least one time per 
day, depending on insulin use and receipt of diabetes education.  Neither concordant 
comorbidities (β=0.226, p=0.086) nor discordant comorbidities (β=0.080, p=0.415) had a direct 
association with the performance of the ADFSE.  The collection of preventive care processes 
demonstrated a 7% (OR: 1.07, 95% CI: 1.05-1.10) increase in the likelihood the ADFSE was 
performed  
Conclusions: Performance of the ADFSE may be improved through multiple types of 
interventions.  Patient-based interventions to increase adherence to self-management behaviors is 
one route.  Programs to improve overall diabetes care in the clinical setting may also help to 
further improve completion of the ADFSE.    
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BACKGROUND 
Physiology and Epidemiology of Diabetes Mellitus 
 According to the estimates by the US Centers for Disease Control and Prevention (CDC) 
and the National Center for Health Statistics, it is estimated that over 30 million people, over the 
age of 18, are currently living with diabetes in the US (1).  Nine percent of US residents have 
been diagnosed diabetes mellitus but nearly 3.0% of the US population remain undiagnosed (2).  
The prevalence is expected to increase to 21-33% by 2050 (3).  Diabetes is a metabolic disease 
that affects the body’s ability to produce or use insulin.  Type 1 diabetes mellitus (T1DM) is 
characterized by the destruction of pancreatic β-cells and an absolute insulin deficiency, affects 
5-10% of the population (4).  Seventy-five percent of TIDM cases occur in children and 
adolescents (5).  Type 2 diabetes mellitus (T2DM) is characterized by the combination of insulin 
resistance in tissues and dysfunctional insulin secretion.  T2DM is the cause of 90-95% of cases 
of diabetes.  Both patient populations could experience periods of hyperglycemia, or plasma 
blood glucose ≥200 mg/dL, which leads to complications.  Some of the common complications 
of diabetes are neuropathy, nephropathy, retinopathy and heart disease (6).  These complications 
are the leading causes of blindness, renal failure and non-traumatic amputations in the US (7).  
As a consequence of these complications, diabetes remains the 7th leading cause of death in the 
United States and resulted in almost 80,000 deaths in 2015 (2).  The total cost of care for 
diabetes is estimated to be over $245 billion, which is more than 2.3 times higher than care for 
those without diabetes (8).  Given the expected increase in prevalence, the high mortality rate 
and high cost of the disease, it is imperative to focus on prevention of diabetes and its 
complications.   
 Much of the healthcare costs for diabetes is due to the complications.  Neurologic 
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complications include peripheral neuropathy (PN), the loss of sensation beginning in the feet and 
hands, which can affect 29-60.8% of the diabetes population (9, 10).  Peripheral vascular disease 
(PVD) and cardiovascular disease (CVD) rates are higher in the diabetes population due to the 
acceleration of atherosclerosis and thrombus formation (6, 11).  About 10% and 32% of people 
with diabetes report PVD and CVD, respectively (9, 12).  Retinopathy affects up to 62% of the 
US diabetes while almost 37% have some degree of chronic nephropathy (8, 10).  Finally, the 
combination of PN and PVD can lead to diabetic foot ulcers (DFU) and lower extremity 
amputations (LEA).   
More than one-quarter of the national spending on neurological, peripheral vascular, 
cardiovascular and renal conditions are attributed to those with diabetes (13).  In 2014, rates of 
hospitalization per 1,000 persons with diabetes were 18.3 for ischemic heart disease, 11.5 for 
cerebrovascular accident (CVA) and 5.0 for LEA (8).  In addition to hospitalization, more than 
14 million people with diabetes visited the emergency department for some type of care.  These 
emergent visits contributed to the average individual annual health care expenditure of $13,700 
(8).   DFUs and LEAs, the result of neuropathy, PVD and CVD, are the leading causes of 
hospitalization and cost the US health care system more than $9 billion (14, 15). 
 
The Diabetic Foot 
 One major complications of diabetes occurs in the foot and is due to the pathophysiology 
of hyperglycemia.  Chronic hyperglycemia leads to both microvascular (PN, retinopathy, and 
nephropathy) and the macrovascular (CVD, PVD) damage to tissues (16-18).  In addition, the 
immune system response is blunted leading to poor wound healing and increased risk of wound 
infection (7).  The development of the diabetic foot usually begins with PN.  Diabetic PN affects 
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the sensory, motor and autonomic branches of the peripheral nervous system (19).  Sensory 
neuropathy results in the loss of ability to detect light touch, vibration, temperature and pain (20).  
In diabetes, sensory neuropathy typically bilateral and begins in the toes and then moves 
proximally as the disease progresses.  As a result, individuals with sensory neuropathy are unable 
to detect minor trauma.  The nerves innervating the intrinsic muscles of the foot are also 
damaged by hyperglycemia and result in motor neuropathy.  The resulting muscle weakness 
leads to skeletal deformities such as hammer toes, claw toes and an unstable arch, which, in turn, 
creates areas of excessive pressure which are prone to tissue injury (7, 19).  Finally, autonomic 
neuropathy leads to impaired blood flow regulation as well as anhidrosis and dry skin that is 
prone to cracking and fissuring (19).  These conditions place the foot at risk for invasion by 
bacteria and fungus and ultimately wound development.   
 
Diabetic Foot Ulcers 
Any injury to the diabetes foot can progress into a DFU.  A DFU results from a break in 
the skin, into or beyond the dermis, which fails to heal in a timely fashion (7, 21).  The most 
common causal pathway for the development of a DFU is through the combination of sensory 
neuropathy, foot deformities from motor neuropathy and minor traumatic events to the feet (22).  
An international clinical study found that among patients with a prior DFU nearly 80% had 
sensory neuropathy, 63% had a foot deformity and 77% reported minor trauma that incited the 
DFU.   Other components of the DFU causal pathway may include: PVD, impaired capillary 
blood flow, the presence of calluses, and edema.  Due to impaired immune system function and 
the high prevalence of decreased blood flow in the diabetes population, DFUs are difficulty to 
heal and prone to infection. 
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 The lifetime risk of developing a DFU can be as high as 34% in the diabetes population 
(23).  The incidence of DFU is estimated between 1.9-4.1% annually and if healed, the 
recurrence rate is as high as 70% (24).  Amongst the Medicare population, the incidence rate is 
higher, at 6.0%, with an annual prevalence of 8.0% (25, 26).  The management of DFUs costs 
the US healthcare system between $9 and $13 billion annually with 77% of the cost is due to 
inpatient hospital admissions (15, 24).   
 
Lower Extremity Amputation 
When medical treatment fails, LEA, the most severe lower extremity consequence of 
diabetes, is the only option (24).  LEAs occur 15 times more often in those with diabetes than in 
those who do not have diabetes, and 85% of all diabetes LEAs are preceded by a DFU (21).  At 
least 5.0 LEAs per 1,000 persons with diabetes were performed in the US in 2014 (8).  LEAs in 
the Medicare population increase average annual reimbursement to over $54,000 (27). 
Perhaps the greatest cost of DFUs and LEAs is mortality.  The 5-year mortality rates for 
diabetes patients is 45-55% and 47% for those with a DFU and LEA, respectively (28).  These 
mortality rates are higher than most cancers, and only pancreatic and lung cancers are more 
deadly (29).  On the contrary, prevention strategies to reduce DFUs and LEAs only cost 10% of 
the total treatment costs for the conditions, making prevention an ideal target to address this large 
public health problem (29, 30). 
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Diabetic Foot Ulcer Prevention and the Recommended Annual Diabetes Mellitus Foot 
Screening Examination 
Evidence has shown that up to 75% of DFUs and 49-85% of LEAs, were preventable 
through cost effective screening and prevention programs (31, 32).  All prevention programs 
begin with foot screening exam to determine the risk of developing a DFU.  The American 
Diabetes Association (ADA) and the International Working Group on the Diabetic Foot 
(IWGDF) recommend an annual diabetes foot screening examination (ADFSE) be performed at 
least once per year on all patients with diabetes over the age of 18 (33-35).  Patients with 
abnormal screenings should have a foot examination on every visit to a health care professional 
(33, 36). 
The ADFSE should include: patient history, general visual foot inspection for 
dermatologic problems, and musculoskeletal, neurologic and vascular examinations.  All 
portions of the ADFSE can be performed by a variety of health care providers including 
physicians, nurses, physical therapists and pharmacists, requires minimal specialty equipment 
and can be performed in less than 5 minutes (37).  Despite these national estimates indicate only 
71% of the US population received the ADFSE in 2012 (38).  Clinical reports of ADFSE 
completion vary from 12% to 95% adherence (39-46).  Prior research has identified race, gender, 
age, education, insurance and rural residency as factors that influence the performance of the 
ADFSE (47-49).  However, other clinically meaningful patient level factors, such as diabetes 
self- management behaviors adherence, the influence of comorbidities and factors related to 
clinical care are still not well understood.  Some of these clinically meaningful patient level 
factors can be explored using a conceptual framework on competing demands presented by 
Piette and Kerr (50). 
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Conceptual Model- Piette and Kerr Framework for Competing Demands 
 The Piette and Kerr framework for competing demands on diabetes care demonstrates 
that diabetes specific care and health are influenced directly by diabetes self-management 
behaviors, diabetes medical management as well as comorbidity self-management behaviors and 
medical management.  Further it suggests that these care processes are not only influenced by 
patients’ and clinicians’ priorities and resources but also by healthcare organizations.  This 
framework has been utilized in prior research to explore how patient level and clinical factors 
have influenced the care of patients with diabetes (51-55).  This dissertation explored the direct 
relationships between performance of the ADFSE and three of the major pathways of the Piette 
and Kerr conceptual model.   
Aim 1.  To determine whether patient performance of 8 individual diabetes mellitus self-
management behaviors are associated with clinicians’ decisions to perform the ADFSE. 
Aim 2.  To assess the simultaneous, direct effects of concordant and discordant comorbidities on 
the performance of the annual diabetes foot screening exam (ADFSE), using structural equation 
modeling (SEM), to simulate clinical decision making. 
Aim 3.  To examine the relationship between the performance of other diabetes preventive care 
processes, number of office visits for diabetes services and the completion of the recommend 
ADFSE. 
 Based on knowledge generated by these studies, clinicians and policy makers will be 
provided with more information on how to improve the performance of the ADFSE.  Improved 
screening of the diabetes foot will lead to early recognition and better management of diabetic 
foot problems, and ultimately reduce the major health and economic burdens for patients with 
diabetes and our society at large.  
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Diabetes Self-management Behaviors and the ADFSE 
 Patient participation in the management of diabetes is imperative to achieving good 
outcomes and preventing complications and is, thus, strongly supported by the ADA and other 
national and international organizations (56-58).  The recommended self-management behaviors 
and reported rates of patient adherence are listed in Table 1-1.  Adherence to these self-
management behaviors can result in improved hemoglobin A1c (HgbA1c) control, reduced 
visceral adipose tissue and plasma triglycerides which, in turn, can reduce the risks of 
comorbidities and complications associated with diabetes, including DFU and LEA (59, 60).  In 
the conceptual model by Piette and Kerr, diabetes self-management behaviors are characterized 
as important factors that could directly influence diabetes health care, including performance of 
the ADFSE (50).   
Table 1-1 - Recommended diabetes self-management 
behaviors and reported rates of adherence (56, 57, 61-
64) 
Diabetes self-management 
behavior  
Reported rate of 
adherence 
Self-monitoring blood glucose 42-64%  
Healthy eating/Diet modification 50-81%  
No smoking 75% 
Self-foot care 20-60%  
Being physical active 50-78%  
Receive influenza vaccination 50% 
Receive pneumococcal 
vaccination 
43% 
 
 A cross-sectional study among patients with T1DM in Pittsburg, Pennsylvania found no 
association between performing self-monitoring of blood glucose (SMBG) at least once per week 
and changing insulin dosing based on blood glucose levels (42).  However, those who performed 
SMBG at least once per day had an almost 2-fold increasing odds of receiving the ADFSE (41).  
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A cross-sectional study among Asian-Americans found no association between tobacco usage 
and alcohol consumption and the performance of the ADFSE (65).  The heterogeneity of the 
study samples, self-management behaviors and preventive care behaviors studied limits 
comparability and generalizability to the US population.  Thus this dissertation aimed to 
determine the association between patient adherence to diabetes self-management ADFSE using 
nationally representative data. 
 
Comorbidities and the ADFSE 
 The medical management of patient with diabetes is complicated by the presence of other 
comorbidities and quality of diabetes care must be viewed in this light.  Diabetes care comes 
with a collection of recommended preventive care processes, including the ADFSE.  All these 
processes must be completed in the limited time available during an office visit along with the 
preventive care processes for other comorbidities.  In clinical practice, the number of 
recommended preventive care processes varies based on each patient’s comorbidities. 
 National estimates showed that amongst those with diabetes in the US, nearly 85% were 
overweight or obese, 57% had hypertension and over 58% had hypercholesterolemia (66).  In 
those aged over 35, coronary artery disease (CAD) and myocardial infarctions (MI) affect nearly 
22% of those with diabetes, while over 9% have suffered a CVA (67).  Nearly 10 years ago, 90% 
of the US diabetes population had at least one other comorbidity and more than a quarter had 5 
or more (68).  Given these high rates of comorbidities and multiple concurrent comorbidities, it 
is imperative to understand how they affect diabetes quality of care, in particular, the ADFSE. 
 The association between comorbidities and diabetes preventive care processes has been 
explored in multiple studies by operationalizing comorbidities as a total count, individual 
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comorbidities or classified as concordant or discordant with diabetes care processes (52, 54, 55, 
68-71).  Thus far, the literature has suggested that comorbidity counts, individual comorbidities, 
and types of comorbidities may all exert an influence on the performance of diabetes preventive 
care processes.   However, no studies in the US have investigated the relationship between 
comorbidities and the ADFSE.  Two international studies found no significant relationship 
between comorbidities classified as concordant or discordant with diabetes care and the 
performance of the ADFSE (72, 73).  Given the paucity of research regarding the association 
between comorbidities and the performance of the ADFSE, this dissertation sought to explore 
these relationships. 
 
Visit Frequency, Competing Demands and the ADFSE 
 The final pathway of the Piette and Kerr model explored in this dissertation was the 
association between  “Diabetes Medical Management”  and overall diabetes care (50).  Diabetes 
medical management can include the provision of preventive care processes, diabetes medication 
management, management of concurrent comorbidities, patient behavior counseling and other 
competing demands (45, 74-76).  Health care providers are faced with the need to prioritize 
delivery of preventive care processes during each patient visit which contributes to the observed 
suboptimal rates of preventive care delivery (74, 77, 78).  Further understanding of the influence 
of these competing demands is necessary to improve the rates of preventive care delivery, 
including the ADFSE for patients with diabetes.   
 No available research has explored the influence of clinical competing demands on 
diabetes care.  However, a study utilizing cross-sectional data from Michigan investigated the 
influence of diabetes preventive care processes on the performance of mammograms and Pap 
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smears in female patients with diabetes (79).  Both the performance of mammograms and Pap 
smears increased significantly as the number of completed diabetes care processes increased.  
While the individual diabetes care processes were not investigated, this study demonstrated 
improved diabetes preventive care positively influences other preventive health care processes in 
the female population.  It is possible that completion of other diabetes preventive care processes 
may help improve rates of completion of the ADFSE.  Unfortunately, no published research has 
directly explored this association.   
Multiple cross-sectional studies have investigated the influence of the number of visits to 
a health provider on the performance of diabetes preventive care processes.  Three studies found 
a positive association between patients having 4 to 8 office visits and the performance of 
HgbA1c testing (65, 68, 80).  Looking specifically at the performance of the ADFSE, positive 
associations between number of visits to a health care provider and the ADFSE were found in 
populations of patients with T1DM, Asian-Americans with diabetes and among participants in 
the Medical Expenditures Panel Survey (MEPS) (41, 65, 68).  Overall, no studies have addressed 
the influence of both clinical competing demands and the patient visits frequency on the 
performance of ADFSE. 
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CHAPTER 2: Description of the dataset 
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THE BEHAVIORAL RISK FACTOR SURVEILLANCE SYSTEM 
 To address the proposed aims, this dissertation used data from the 2015 Behavioral Risk 
Factor Surveillance System (BRFSS).  The BRFSS is a cross-sectional, annual survey 
administered by the CDC and conducted via land-line and cellular telephones (81).  The BRFSS 
interviews non-institutionalized US residents, over the age of 18 years.  The system is designed 
to collect information on preventive health care practices, health risk behaviors, chronic diseases, 
injuries and preventable infectious diseases that affect the US adult population.  Data is collected 
by each state’s health department, using computer aided telephone interviewing, to provide state-
specific information.  Data is then compiled into a national database by the CDC.  The methods 
for sample weighting to account for the complex sample design are described elsewhere (82).  
For this study, the BRFSS sample weighting was utilized to determine nationally representative 
estimates.   
The BRFSS utilizes a disproportionate stratified sample study design to collect the 
landline samples (81).  Since 2008, sampling frames for cellular telephones are obtained from the 
Telecordia database.  The BRFSS questionnaire is comprised of a core component, conducted in 
every state, and optional modules on specific topics, including diabetes (81).  The core 
component gathers demographic information, health conditions and health behaviors.  Each state 
then determines which optional modules to conduct.  The states participating in each optional 
module are available online (83).   
An optional module, asking 10 questions specific to diabetes care is available in the 2015 
BRFSS dataset.  In 2015, 38 states participated in the diabetes optional module (83).  All survey 
respondents who responded “yes” to the question “Has a doctor, nurse or other health 
professional every told you that you have diabetes?” in the core component were included in the 
16 
 
sample eligible to participate in the diabetes optional module.  Respondents indicating the 
diagnosis of gestational, borderline or pre-diabetes were excluded from the diabetes Module.  
The diabetes module includes questions about diabetes specific self-management activities and 
recommended preventive care processes.  However, the module did not include information on 
use of oral medications to manage diabetes.  While the module did ask respondents if they used 
insulin, it did not include information type of insulin use (basal rate vs. basal rate and bolus).  A 
total of 38,224 BRFSS participants were eligible to participate in the optional diabetes module. 
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CHAPTER 3: Are Diabetes Mellitus Self-management Behaviors Associated with the 
Receipt of the Recommended Annual Diabetes Foot Screening Examination? 
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ABSTRACT 
Objective: To determine whether patient performance of 8 individual diabetes mellitus self-
management behaviors are associated with clinicians’ decisions to perform the annual diabetes 
foot screening exam (ADFSE). 
Research Design and Methods: We utilized the 2015 BRFSS data from 38 states (n=14,825) to 
conduct a cross-section study.  Respondents who provided a valid responses for the ADFSE and 
had at least one visit to a healthcare providers in the past 12 months were included.  Eight 
separate multivariable logistic regression models were evaluated to assess the association 
between the self-management behaviors and the performance of the ADFSE.   
Results: Among adults with diabetes mellitus and at least one visit to a health provider, 78.3% 
received an ADFSE.  The most commonly performed self-management behaviors were 
performance self-monitoring of blood glucose (SMBG) and self-foot inspections, both at least 
one time per day.  After controlling for covariates, performance of the ADFSE was 77% less 
likely (OR: 0.33, 95%CI: 0.25-0.44) in those who do not perform self-foot inspections and 40% 
less likely (OR: 0.59, 95%CI: 0.45-0.76) in those who have never received the pneumococcal 
vaccination.  Patients who do not perform SMBG and do not use insulin or have not had formal 
diabetes education are 48% less likely (OR: 0.52, 95%CI: 0.38-0.82, OR: 0.52, 95%CI: 0.36-
0.74, respectively) to receive the ADFSE.  Finally, those who do not practice SMBG and did 
receive diabetes education are 81% less likely (OR: 0.19, 95%CI: 0.09-0.94) to receive the 
ADFSE.   
Conclusions: Some diabetes mellitus self-management behaviors are associated with the 
performance of the ADFSE.  Future exploration of the casual relationship between diabetes 
mellitus self-management behaviors and the resultant effects on the performance ADFSE will 
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provide further information on potential intervention that can increase the performance of this 
potentially life-saving screening exam. 
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INTRODUCTION 
The lifetime risk of developing a diabetic DFU can be as high as 34% (23).  In 2010, 
more than 77,000 people were hospitalized with an infected DFU and 17% of cases resulted in 
an LEA (84).  The management of DFUs costs the US healthcare system more than $9-13 billion 
per year, in addition to the baseline cost of the care for diabetes mellitus (15).  Despite advances 
in wound care, more than 60% of DFUs remain unhealed after 20 weeks of standard wound care 
(85).  The 5-year mortality rate for the population with a DFU or LEA resulting from a DFU is 
between 29% and 50% (28, 86). 
Evidence has shown that up to 75% of DFUs and 49-85% of LEAs were preventable 
through cost effective screening and prevention programs (31, 32).  Primary prevention of DFUs 
in the general US population with diabetes can be effective and cost-saving, however, in 2015 
only 71.6% of the US population with diabetes received an ADFSE (87, 88).  While the rates of 
ADFSE performance, based on national surveys, have increased from 64.6% in 2002 to 71.6% in 
2015, more than 8.6 million US residents with diagnosed diabetes did not received the ADFSE in 
2015 (1, 89).  Given the ADFSE is both cost-saving for the US health system and the first step in 
prevention efforts, it is imperative to identify populations at risk of not being screened and 
promote effective interventions to increase ADFSE rates (87). 
A conceptual model to describe competing demands for diabetes care, developed by 
Piette and Kerr, describes diabetes self-management behaviors as an important factor that could 
directly influence the provision of diabetes-specific care, including the ADFSE (50).  While 
previous studies have utilized this framework to explore how patient level and clinical factors 
influence the care of patients with diabetes, none have explored the role of self-management 
behaviors on the performance of the ADFSE (51, 52, 54, 55). 
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Prior studies have found the performance of some diabetes self-management behaviors 
have positive associations with the performance of diabetes specific screening procedures, such 
as fasting lipid profiles, urine protein analysis and HgbA1c testing (41, 42, 65).  Other studies 
specifically examined the performance of the ADFSE.  Among a small sample of individuals 
with T1DM, weekly SMBG did not influence the performance of the ADFSE nor other screening 
procedures.  However, when SMBG was performed at least once daily in this study population, 
the odds of patients receiving the ADFSE nearly doubled (41).  A study among a nationally 
representative sample of Asian-Americans with diabetes mellitus found no relationships between 
tobacco usage and alcohol consumption and the performance of the ADFSE (65). 
Overall the literature on the association between diabetes self-management behaviors and 
the performance of the ADFSE is limited.  The heterogeneity of the study samples, self-
management behaviors and preventive care behaviors studied limit comparability and 
generalizability.  Thus, the objective of the current study was to determine whether patient 
completion of 8 individual diabetes mellitus self-management behaviors are associated with 
clinicians’ decision to perform the ADFSE.   
 
RESEARCH DESIGN AND METHODS 
Data Source and Sample 
This was a cross-section study using data from the 2015 BRFSS.  The BRFSS is designed 
to collect information on preventive health care practices, health risk behaviors, chronic diseases, 
injuries and preventable infectious diseases among non-institutionalized US residents, over the 
age of 18 years (81).  The methods for sample weighting to account for the complex sample 
design are described elsewhere (82).   
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An optional module, asking 10 questions specific to diabetes care was available in the 
2015 BRFSS dataset (90).  In 2015, 38 states participated in the Diabetes Mellitus Optional 
Module (Arizona, California, Colorado, Connecticut, Delaware, District of Columbia, Florida, 
Georgia, Hawaii, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maryland, Michigan, 
Minnesota, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, 
North Carolina, Oklahoma, Pennsylvania, Rhode Island, South Carolina, Tennessee, Texas, 
Vermont, Utah, Virginia, Washington, Wisconsin, Wyoming) (83).  The Diabetes Mellitus 
Optional Module includes questions about diabetes mellitus specific self-management activities 
and recommended preventive care processes, including the ADFSE.  All survey respondents who 
responded “yes” to the question “Has a doctor, nurse or other health professional every told you 
that you have diabetes?” in the core component were included in the sample eligible to 
participate in the Diabetes Mellitus Optional Module.  Respondents indicating the diagnosis of 
gestational, borderline or pre-diabetes mellitus were excluded from the Diabetes Mellitus 
Optional Module in the BRFSS survey design.  A total of 36,085 of the 2015 BRFSS participants 
were eligible to participate in the Diabetes Mellitus Optional Module.  
To be included in the study sample respondents must have a valid response to the study 
outcome question, at least one foot and had at least one visit to a health provider for diabetes 
mellitus care in the past year.  One thousand, nine hundred and sixty-five respondents did not 
provide a valid response to the outcome question and were thus excluded from the study.  The 
BRFSS question “About how often do you check your feet for any sores or irritations?” was used 
to identify respondents without feet.  Three-hundred and forty-nine individuals gave the response 
of “no feet” were excluded from the analytic sample.  Having at least one visit to a health 
provider for diabetes mellitus care in the past year was determined utilizing the question “About 
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how many times in the past 12 months have you seen a doctor, nurse or other health professional 
for your diabetes?”  The responses were dichotomized to “yes- at least one visit” or “no, no 
visits.”  Respondents who had no visits to a health provider or did not provide a valid response 
were excluded from the study sample (n=3,656).  BRFSS respondents who did not provide a 
valid response for all exposure, covariate and confounding variables were also excluded 
(n=15,292).  After all exclusions were considered, the total sample size for this study was 
14,823. 
 
Measures 
 The primary outcome of this study was defined as having at least one ADFSE in the past 
year.  The study outcome variable was created from the question “About how many times in the 
past 12 months has a health professional checked your feet for any sores or irritations?”  
Continuous numerical responses were dichotomized to “yes, at least one time” or “no.”  The 
main exposures of interest for this study were self-management behaviors for people with 
diabetes mellitus that were included in the 2015 BRFSS questionnaire.  These behaviors included 
SMBG, performance of daily self-foot inspections, annual receipt of the influenza vaccine, 
receipt of a pneumococcal vaccine at any time, meeting aerobic and resistance exercise 
recommendations, smoking status, and alcohol consumption. 
 The 2015 BRFSS Diabetes Module asked respondents “About how often do you check 
your blood for glucose or sugar?”  Responses were given as continuous number of times per day, 
week, month or year.  Based on the goal for Healthy People 2020 the variable was dichotomize 
to “yes, at least one time per day” and “no, less than one time per day” (91).  The International 
Working Group for the Diabetic Foot recommends people with diabetes mellitus , or their 
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caregiver, visually inspect their feet for changes on a daily basis (36).  Thus the original, 
continuous responses to the question “About how often do you check your feet for any sores or 
irritations?” was dichotomized to “yes, at least one time per day” and “no, less than one time per 
day.”  For the receipt of the influenza vaccine in the past 12 months, the question “During the 
past 12 months, have you had either a flu shot or a flu vaccine that was sprayed in your nose?” 
was utilized.  Receipt of the pneumonia vaccine was determined by the question “Have you ever 
had a pneumonia shot?”  For both vaccination questions the original responses to the questions 
were either “yes received vaccine” or “no did not receive vaccination.”  Based on ADA 
recommendations, the 2015 BRFSS used data collected from multiple questions to calculate a 
variable to indicate if a respondent “participated in 150 minutes (or vigorous equivalent of 
minutes) of physical activity per week” (56). These responses were categorized by BRFSS as 
“yes, performed 150+ minutes of physical activity per week” and “no, did not perform 150 
minutes of physical activity per week.”  The ADA also recommends performance of resistance 
exercise training 2 days per week (56).  The 2015 BRFSS contains the question “During the past 
month, how many times per week or per month did you do physical activities or exercises to 
strengthen your muscles?” was used.  Responses are given as the number of days per week or 
month.  This study dichotomized responses to “met recommendation” and “did not meet 
recommendations.”  The BRFSS contains a calculated variable to indicate if a respondent was a 
current smoker or not and this was utilized without change (90).  Finally, the ADA recommends 
that males with diabetes mellitus drink no more than 2 alcoholic beverages per day and women 
no more than one per day (56).  The 2015 BRFSS contains a variable that indicates whether a 
male had more than 14 drinks per week and a women had more than 7 drinks per week and this 
was used to define a variable for excessive alcohol usage (yes/no) (90). 
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 To increase comparability with existing literature this study utilized covariates similar to 
variables utilized in prior research (41, 65, 92, 93).  These included sex, age, race, education, 
marital status, annual household income and insurance status.  Potential confounders included 
the number of visits to a health provider for diabetes mellitus care, number of years with diabetes 
mellitus, self-reported health status and comorbidities including hypertension, 
hypercholesterolemia, CVD, obesity, and depression.  These potential confounders have all been 
shown to be associated with adherence to self-management in people with diabetes mellitus (41, 
51, 65, 94, 95).  Previous studies have shown that insulin use and formal diabetes mellitus 
education modify the association between a diabetes self-management behavior and the 
performance of diabetes mellitus preventive care processes (65, 93, 94).  Thus, this study 
assessed insulin use and receipt of diabetes mellitus education as potential effect modifiers. 
 
Statistical Analysis 
 All analyses were conducted with adjustments for the complex sample design of the 
BRFSS to provide population estimates that represent the 38 states that participated in the 2015 
Diabetes Mellitus Optional Module (82).  Descriptive statistics for the total study population and 
stratified by who received and did not received the ADFSE, were calculated for all variables.  
The sub-populations were compared through chi-squared tests to determine if statistically 
significant differences existed between the study groups. 
 Eight separate multivariable logistic regression models were evaluated to assess the 
association between each of the self-management behaviors and the ADFSE.    Hierarchical 
backward elimination was conducted to identify a parsimonious model for each self-management 
behavior (96).  Initial models contained a single self-management behavior, all covariates, all 
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confounders and both effect modifiers.  First, one-way effect modifications, by status of insulin 
use or receipt of diabetes mellitus education, were assessed.  Full and reduced models were 
compared using the likelihood ratio test where p<0.05 was considered a significant difference 
between models.  Significant interactions (p<0.05) were retained in the model and the results 
were stratified by the effect modifier for reporting.  Following assessment for effect 
modification, confounding was assessed using the 10% change-in-estimate method (96). 
 Sensitivity analyses were conducted for each model to determine the potential for bias 
due to non-response to the study outcome of interest.  For this analysis, the 1,965 respondents, 
originally excluded for an invalid response to the outcome question, were classified as either all 
having had the ADFSE or all not having had the ADFSE.  The final models for each of the eight 
self-management behaviors were then re-calculated to determine the odds ratios and 95% CIs 
assuming the missing respondents did or did not receive the ADFSE.  All analyses for this paper 
were generates using SAS version 9.4 (SAS Institute Inc., Cary, NC, USA).  
 
RESULTS 
Table 1 presents the weighted percentages of the characteristics of the study population 
(n=14,823).  In 2015, 78.3% of persons aged 18 years and older, with diagnosed diabetes 
mellitus and at least one visit to a healthcare provider for diabetes mellitus care received at least 
ADFSE in the past 12 months.  Fifty-one and nine-tenths percent (59.1%) of the population with 
diabetes mellitus were male, 59.4% were under the age of 65 years and 60.1% were non-
Hispanic white.  Nearly 95% of people with diabetes mellitus had some form of health insurance.  
A majority of the study population reported having hypertension (71.9%) and high cholesterol 
(64.3%), while 24.2% reported some type of CVD and 23.9% reported having depression.  A 
27 
 
majority of the study population received formal diabetes mellitus education (59.0%), reported 
time since diagnosis of diabetes mellitus of 10-19 years (34.8%) and “good” or better self-rated 
health (55.1%).   
Table 3-1- Characteristics of persons aged ≥18 years with diagnosed diabetes, 38 states (n=14,823)* 
  
Study population 
 
 
%                SE 
Received annual diabetes foot screening 
exam in past 12 months 
              Yes                                 No      
        78.3±1.10%†               21.7±1.10 %†         
      %                SE                %                SE            
P value‡ 
Sex 
   Male 
   Female 
 
51.9 
48.1 
 
1.3 
1.3 
 
52.7 
47.3 
 
1.4 
1.4 
 
49.1 
50.9 
 
2.9 
2.9 
 
0.273 
 
Age (years) 
   18-64 
   ≥65 
 
59.4 
40.6 
 
1.2 
1.2 
 
58.0 
42.0 
 
1.4 
1.4 
 
64.7 
35.3 
 
2.7 
2.7 
 
0.0322 
Race 
   Non-Hispanic white 
   Non-Hispanic black 
   Hispanic 
   Other 
 
60.1 
15.0 
16.9 
5.0 
 
1.4 
0.8 
1.4 
1.1 
 
61.5 
15.9 
14.6 
7.9 
 
1.5 
0.9 
1.4 
1.3 
 
54.7 
11.7 
25.2 
8.4 
 
3.1 
1.4 
3.5 
1.8 
 
0.0016 
Education 
   Less than high school 
   High school graduate 
   Some college 
   College graduate 
 
18.6 
29.5 
31.9 
20.0 
 
1.2 
1.0 
1.2 
1.0 
 
17.7 
29.2 
33.0 
20.1 
 
1.3 
1.1 
1.3 
1.2 
 
22.0 
30.6 
28.1 
19.3 
 
3.2 
2.6 
2.3 
2.0 
 
0.2376 
 
Marital status 
   Married 
   Divorced/separated 
   Widowed 
   Never married 
 
62.5 
16.6 
12.1 
8.8 
 
1.1 
0.7 
0.6 
0.5 
 
62.5 
16.6 
12.2 
8.7 
 
1.2 
0.8 
0.6 
0.6 
 
62.5 
16.5 
11.6 
9.4 
 
2.5 
1.6 
1.2 
1.3 
 
0.9332 
 
Annual household income 
   <$15,000 
   $15,000-<$25,000 
   $25,000-<$35,000 
   $35,000-<$50,000 
    ≥$50,000 
 
15.4 
21.9 
12.3 
13.1 
37.5 
 
1.0 
1.1 
0.8 
0.6 
1.3 
 
15.0 
20.8 
12.1 
13.4 
38.8 
 
1.1 
1.1 
0.8 
0.7 
1.4 
 
16.4 
26.0 
13.0 
11.8 
32.8 
 
2.4 
3.0 
1.8 
1.4 
2.5 
 
0.1546 
Health insurance 
   Yes 
   No 
 
93.9 
6.1 
 
0.8 
0.8 
 
94.5 
5.5 
 
0.9 
0.9 
 
91.8 
8.2 
 
1.8 
1.8 
 
0.1350 
 
Use insulin 
   Yes 
   No 
 
34.0 
66.0 
 
1.1 
1.1 
 
36.8 
63.2 
 
1.3 
1.3 
 
23.8 
76.2 
 
2.3 
2.3 
 
<0.0001 
Received diabetes mellitus 
education 
   Yes 
   No 
 
 
59.0 
41.0 
 
 
1.2 
1.2 
 
 
62.1 
37.9 
 
 
1.3 
1.3 
 
 
47.7 
52.3 
 
 
3.0 
3.0 
 
 
<0.0001 
Time since diagnosis with 
diabetes mellitus 
  0-4 years 
   5-9 year 
   10-19 years 
 
 
18.4 
17.4 
34.3 
 
 
1.0 
1.0 
1.3 
 
 
16.0 
17.9 
33.8 
 
 
1.0 
1.1 
1.4 
 
 
27.2 
15.7 
36.3 
 
 
2.4 
1.4 
3.2 
 
 
<0.0001 
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   20-29 years 
   30+ years 
15.5 
15.4 
0.9 
0.7 
15.8 
16.5 
1.1 
0.8 
9.5 
11.3 
1.3 
1.4 
Self-reported health status 
   Excellent 
   Very good 
   Good 
   Fair 
   Poor 
 
2.5 
16.5 
36.1 
30.4 
15.6 
 
0.3 
0.8 
1.2 
1.2 
1.1 
 
2.5 
16.7 
35.8 
30.3 
14.7 
 
0.3 
0.9 
1.3 
1.3 
1.3 
 
2.3 
15.8 
37.1 
30.8 
13.9 
 
0.4 
1.9 
2.7 
3.1 
1.6 
 
0.9722 
Hypertension 
   Yes 
   No 
 
71.9 
28.1 
 
1.3 
1.3 
 
72.7 
27.3 
 
1.4 
1.4 
 
68.9 
31.1 
 
3.0 
3.0 
 
0.2468 
High cholesterol 
   Yes 
   No 
 
64.3 
35.7 
 
1.3 
1.3 
 
64.5 
35.5 
 
1.5 
1.5 
 
63.8 
36.2 
 
3.0 
3.0 
 
0.8531 
Cardiovascular disease 
   Yes 
   No 
 
24.2 
75.8 
 
1.0 
1.0 
 
25.6 
74.4 
 
1.2 
1.2 
 
19.0 
81.0 
 
1.7 
1.7 
 
0.0019 
Depression 
   Yes 
   No 
 
23.9 
76.1 
 
1.0 
1.0 
 
23.5 
76.5 
 
1.1 
1.1 
 
25.0 
75.0 
 
2.1 
2.1 
 
0.5241 
Visits to health provider for 
diabetes mellitus care 
   1 visit 
   2 visits 
   3 visits 
   4 visits 
   5+ visits 
 
 
16.0 
23.5 
16.7 
27.4 
16.4 
 
 
0.9 
1.2 
1.0 
1.1 
1.0 
 
 
13.4 
23.0 
16.9 
29.9 
16.8 
 
 
0.8 
1.2 
1.1 
1.3 
1.2 
 
 
25.4 
24.5 
15.6 
18.5 
15.1 
 
 
2.4 
3.1 
1.6 
2.2 
1.9 
 
<0.0001 
 
BMI 
   Underweight 
   Normal 
   Overweight 
   Obese 
 
0.5 
12.7 
32.9 
53.9 
 
0.1 
0.8 
1.3 
1.3 
 
0.4 
12.8 
32.9 
53.9 
 
0.1 
0.9 
1.5 
1.4 
 
0.5 
12.3 
32.8 
53.9 
 
0.5 
1.6 
2.8 
2.9 
 
0.4907 
 
* The 38 states include: Arizona, California, Colorado, Connecticut, Delaware, District of Columbia, Florida, 
Georgia, Hawaii, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maryland, Michigan, Minnesota, 
Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, Oklahoma, 
Pennsylvania, Rhode Island, South Carolina, Tennessee, Texas, Vermont, Utah, Virginia, Washington, 
Wisconsin, and Wyoming. † Percentage of population ± SE. ‡ P-values from χ2 test.   
 
Examining the population who received the ADFSE, we found that 52.7% were male and 
58.0% were under the age of 65 and 94.5% had some form of health insurance.  The distribution 
of race in those who received the ADFSE was: 61.5% non-Hispanic white, 15.9% non-Hispanic 
black, 14.6% Hispanic and 7.9% reported another race.  A majority of patients who received the 
ADFSE received at least some college level education (53.1%), were married (62.5%), reported 
an annual household income over $35,000 (52.2%), have had diabetes more than 10 years 
(66.1%), reported at least “good” self-rated health (55.0%) and reported 3 or more visits to a 
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healthcare provider for diabetes care (63.6%).  Among those who received the ADFSE, 72.7% 
had hypertension, 64.5% have high cholesterol, 25.6% report CVD, 23.5% have depression and 
86.8% were overweight or obese.   
The population who did not receive the ADFSE were 49.1% male, 64.7% were under the 
age of 65 and 91.8% had health insurance.  Upon examining race, of those who did not receive 
the ADFSE 54.7% were non-Hispanic white, 11.7% were non-Hispanic black, 25.2% were 
Hispanic and 8.4% were of other races.  A majority of the population who did not receive the 
ADFSE had less than a high school level education or only graduated from high school (52.6%), 
were married (62.5%), and had an annual income less than $35,000 (55.4%), have had diabetes 
over 10 years (57.1%), reported at least “good” self-rated health (55.2%) and reported having 3 
or more visits to a healthcare provider for diabetes care (50.1%).  When comorbidities are 
explored, 68.9% had hypertension, 63.8% have high cholesterol, 10% report having CVD, 25.0% 
have depression and 86.7% are overweight or obese.   
Table 2 presents the reported performance of recommended diabetes self-management 
behavior in the study population.  The two most often performed behaviors were SMBG at least 
one time per day (89.9%) and self-foot exam at least one time per day (87.4%).  The two least 
commonly performed behaviors are currently smoking (13.4%) and drinking excessive amounts 
of alcohol (2.1%).  The rates of performance of the other diabetes self-management behaviors 
were: 59.0% received the influenza vaccine in the past 12 months, 61.6% have received a 
pneumococcal vaccine, 44.2% met aerobic activity recommends and 19.6% met resistance 
training recommendations. 
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Table 3-2- Reported performance of recommended diabetes mellitus self-management behaviors 
in persons aged ≥18 years with diagnosed diabetes, 38 states (n=14,823)* 
  
Study population 
 
 
%                SE 
Received annual diabetes foot screening 
exam in past 12 months 
              Yes                                 No      
        78.3±1.10%†               21.7±1.10 %†         
      %                SE                %                SE            
P value‡ 
Perform self-monitoring of 
blood glucose ≥1 time per 
day 
   Yes 
   No 
 
 
 
89.9 
10.1 
 
 
 
0.7 
0.7 
 
 
 
91.2 
8.8 
 
 
 
0.8 
0.8 
 
 
 
85.4 
14.6 
 
 
 
1.5 
1.5 
0.0004 
Perform self-foot exam  ≥1 
time per day 
   Yes 
   No 
 
 
87.4 
12.6 
 
 
0.7 
0.7 
 
 
90.7 
9.3 
 
 
0.7 
0.7 
 
 
75.3 
24.7 
 
 
2.1 
2.1 
<0.0001 
Receive influenza vaccine 
in past 12 months 
   Yes 
   No 
 
 
59.0 
41.0 
 
 
1.3 
1.3 
 
 
60.5 
39.5 
 
 
1.4 
1.4 
 
 
53.5 
46.5 
 
 
2.9 
2.9 
0.0272 
 
Ever receive pneumococcal 
vaccine 
   Yes 
   No 
 
 
61.6 
38.4 
 
 
1.3 
1.3 
 
 
64.7 
35.3 
 
 
1.4 
1.4 
 
 
50.3 
49.7 
 
 
2.9 
2.9 
<0.0001 
Met aerobic activity 
recommendations§ 
   Yes 
   No 
 
 
44.2 
55.8 
 
 
1.3 
1.3 
 
 
45.7 
54.3 
 
 
1.4 
1.4 
 
 
38.7 
61.3 
 
 
2.7 
2.7 
0.0217 
Met resistance training 
recommendations|| 
   Yes 
   No 
 
 
19.6 
80.4 
 
 
1.0 
1.0 
 
 
20.8 
79.2 
 
 
1.2 
1.2 
 
 
15.2 
84.8 
 
 
1.9 
1.9 
0.0193 
Current smoking status 
   Yes 
   No 
 
13.4 
86.6 
 
0.9 
0.9 
 
13.3 
86.7 
 
1.1 
1.1 
 
13.8 
86.2 
 
1.6 
1.6 
0.8249 
Excessive alcohol 
consumption¶ 
   Yes 
   No 
 
 
2.11 
97.9 
 
 
0.3 
0.3 
 
 
2.3 
97.7 
 
 
0.4 
0.4 
 
 
1.3 
98.7 
 
 
0.3 
0.3 
0.0323 
* The 38 states include: Arizona, California, Colorado, Connecticut, Delaware, District of Columbia, Florida, 
Georgia, Hawaii, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maryland, Michigan, Minnesota, 
Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, Oklahoma, 
Pennsylvania, Rhode Island, South Carolina, Tennessee, Texas, Vermont, Utah, Virginia, Washington, 
Wisconsin, Wyoming.. † Percentage of population ± SE. ‡ P-values from χ2 test.  § ≥150 minutes of moderate 
aerobic exercise per week. || Perform resistance training ≥2 days per week.  ¶ Males- no more than 2 and women 
no more than 1 alcoholic beverage per day. 
 
When only those who received the ADFSE are examined, 91.2% complete SMBG at 
least one time per day and 90.7% perform a self-foot check at least one time per day.  This 
population reports rates of smoking (2.3%) and excessive alcohol consumption (13.3%) at higher 
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rates than the general population with diabetes.  Of the ADFSE recipients 60.5% received the 
influenza vaccine in the past 12 months, 64.7% received the pneumococcal vaccine, 45.7% 
performed the recommended amount of aerobic activity and 20.8% performed the recommended 
amount of resistance training.    
Reported rates of SMBG at least one time per day (85.4%) and self-foot exams at least 
one time per day (75.3%) were lower among those who did not receive the ADFSE.  The other 
rates of completion were also lower in the population who did not receive the ADFSE.  The 
influenza vaccine was received by only 53.5% and pneumococcal vaccine was received by 
50.3% of those who did not also receive the ADFSE.  Finally, only 38.7% and 15.2% of patients 
performed the recommended amounts of aerobic and resistance training, respectively.   
Table 3 shows the results from the 8 multiple logistic regression models to describe the 
association between each diabetes mellitus self-care behaviors and the performance of the 
ADFSE.  The status of insulin use was found to modify the association between receipt of the 
influenza vaccine (p=0.006), performance of the recommended dosage of aerobic exercise 
(p=0.036) and avoidance of excessive alcohol consumption (p=0.034) and performance of the 
ADFSE.  
The receipt of the influenza vaccine and the performance of the recommended dosage of 
aerobic exercise did not demonstrate significant associations with the performance of the 
ADFSE, in either subpopulation.  A positive association was found in the population that do not 
use insulin and consume an excessive quantify of alcohol.  Among those who do not use insulin 
and do consume an excessive amount of alcohol there is more than 3 times increased odds (OR: 
3.14, 95%CI: 1.45-3.91) ADFSE is performed compared to those who do not use insulin and 
avoid excessive alcohol usage.  
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Table 3-3- Multiple Logistic Regression Model Estimates of Odds Ratios (OR) and 95% CI for the 
association between patient performance of 8 individual diabetes mellitus self-management behaviors  on 
the performance of the recommended annual diabetes foot screening examination (n=14,823) 
Recommended self-
management behavior  
Effect modification Self-management behavior 
Met recommendation  
 
Did not meet 
recommendation OR 
(95% CI) 
Self-monitor blood 
glucose ≥1/per day* 
Use insulin Reference 1.67 (0.79-2.43) 
Do not use insulin Reference 0.52 (0.38-0.82) 
Had diabetes mellitus 
education 
Reference 0.19 (0.09-0.94) 
No diabetes mellitus 
education 
Reference 0.52 (0.36-0.74) 
Perform self-foot check 
≥1/per day† 
None Reference 0.33 (0.25-0.44) 
Received influenza 
vaccine ≤12 months* 
Use insulin Reference 1.78 (0.86-2.50) 
Do not use insulin Reference 0.90 (0.68-1.19) 
Ever receive 
pneumococcal vaccine* 
None Reference 0.59 (0.45-0.76) 
Perform ≥150 minutes of 
moderate aerobic exercise 
per week* 
Use insulin Reference 1.60 (0.75-2.36) 
Do not use insulin Reference 0.90 (0.69-1.18) 
Perform resistance 
training ≥2 days per 
week* 
None Reference 0.71 (0.51-0.98) 
 No smoking* None Reference 0.95 (0.69-1.30) 
Avoid excessive alcohol 
consumption‡ 
Use insulin Reference 0.86 (0.31-1.87) 
Do not use insulin Reference 3.14 (1.45-3.91) 
Bolded ORs and 95% CI indicate significance at p<0.05.  All models adjusted for covariates: sex, age, race, 
education, marital status, annual household income and insurance status. *Adjusted for covariates only.  † 
Adjusted for covariates and duration of time with diabetes mellitus.  ‡ Adjusted for covariates and number of 
visits to a health provider for diabetes mellitus care. 
  
Both status of insulin use (p=0.0108) and of the receipt of formal diabetes education 
(p=0.0336) were found to be significant effect modifiers of the relationship between performance 
of SMBG at least one time per day and the receipt of the ADFSE.  Among those who used 
insulin, performance of SMBG was not significantly associated with the performance of the 
ADFSE (OR: 1.67, 95%CI: 0.79-2.43).  For the group that does not use insulin, those who do not 
perform SMBG at least one time per day were nearly 50% less likely to receive the ADFSE (OR: 
0.52, 95%CI: 0.38-0.82) compared to those who do perform SMGB at least one time per day.  
When effect modification based on receipt of formal diabetes education was explored, both 
statuses demonstrated a significant association between performance of SMBG at least one time 
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per day and performance of the ADFSE.  Among those who receive formal diabetes education, 
those who do not perform SMBG at least one time per day were more than 20% less likely to 
receive the ADFSE (OR: 0.19, 95% CI: 0.09-0.94) compared to those who do perform the 
behavior.  Finally, those who do not receive formal diabetes and do not perform the SMBG 
activity nearly 50% less likely to receive the ADFSE (OR: 0.52, 95%CI: 0.36-0.74) compared to 
those who perform SMBG at least one time per day.   
No statistically significant one-way effect modifications were demonstrated between the 
remaining four self-management behaviors (perform daily self-foot check, receipt of 
pneumococcal vaccine, resistance exercise and smoking status) and performance of the ADFSE.  
The model results demonstrated that not performing daily self-foot checks, non-receipt of the 
pneumococcal vaccination and not performing the recommended dosage of resistance exercise 
all have a negative association with the receipt of the ADFSE.  Those who do not perform a daily 
self-foot check are 67% less likely (OR: 0.33, 95%CI: 0.25-0.44) to receive the ADFSE 
compared to those who do perform a daily self-foot check.  Those who do not receive a 
pneumococcal vaccination are nearly 40% less likely (OR: 0.59, 95%CI: 0.45-0.76) to receive 
the ADFSE compared to those who have received the vaccination.  And those who do not 
perform resistance training at least 2 times week, are almost 30% less likely (OR: 0.71, 95%CI: 
0.51-0.98) to receive the ADFSE, compared to those who perform the recommended dosage of 
resistance training.  Finally, no significant association (OR: 0.95, 95%CI: 0.69-1.30) was found 
between current smoking status and receipt of the ADFSE. 
Finally, Table 4 presents the results of the sensitivity analysis for non-response bias.  The 
results demonstrfate no significant non-response bias.  
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Table 3-4- Multiple logistic regression model estimates of odds ratios (OR) and 95% CI to assess 
for outcome non-response bias in estimates for the influence of patient performance of 8 
individual diabetes mellitus self-management behaviors on the performance of the recommended 
annual diabetes foot screening examination. 
 Model estimate 
OR (95% CI) 
Assuming all 
non-responders 
received ADFSE 
OR (95% CI) 
Assuming no 
non-responders 
received ADFSE 
OR (95% CI) 
Perform self-monitoring of blood glucose ≥1 time per 
day 
   Use insulin, received diabetes mellitus education 
   No insulin use, received diabetes mellitus education 
   Use insulin, no diabetes mellitus education 
   No insulin use, no diabetes mellitus education   
 
 
0.62 (0.17-1.27) 
1.67 (0.54-5.15) 
0.19 (0.07-0.50) 
0.52 (0.36-0.74) 
 
 
0.54 (0.15-1.96) 
1.43 (0.53-3.86) 
0.22 (0.10-0.48) 
0.57 (0.40-0.80) 
 
 
0.51 (0.11-2.40) 
1.34 (0.44-4.14) 
0.21 (0.08-0.56) 
0.57 (0.39-0.82) 
Perform self-foot exam  ≥1 time per day 0.33 (0.25-0.44) 0.39 (0.30-0.51) 0.40 (0.30-0.51) 
Receive influenza vaccine in past 12 months 
   Use insulin 
   No insulin use 
 
1.78 (0.86-2.50) 
0.90 (0.68-1.19) 
 
1.38 (0.81-1.91) 
0.84 (0.64-1.10) 
 
1.39 (0.83-1.91) 
0.86 (0.66-1.12) 
Ever receive pneumococcal vaccine 0.59 (0.45-0.76) 0.58 (0.45-0.74) 0.59 (0.46-0.75) 
Met aerobic activity recommendations* 
   Use insulin 
   No insulin use 
 
1.60 (0.75-2.36) 
0.90 (0.69-1.18) 
 
1.50 (0.92-1.98) 
0.90 (0.69-1.16) 
 
1.53 (0.96-2.00) 
0.92 (0.71-1.18) 
Met resistance training recommendations† 0.71 (0.51-0.98) 0.72 (0.55-1.00) 0.76 (0.57-1.01) 
Current smoking status 0.95 (0.69-1.30) 0.94 (0.69-1.28) 0.93 (0.69-1.25) 
Excessive alcohol consumption ‡ 
   Use insulin 
   No insulin use 
 
0.86 (0.31-1.87) 
3.14 (1.45-3.91) 
 
0.66 (0.33-1.34) 
2.16 (1.12-2.81) 
 
0.69 (0.36-1.36) 
2.14 (1.12-2.79) 
* ≥150 minutes of moderate aerobic exercise per week. † Perform resistance training ≥2 days per week.  ‡ Males- 
no more than 2 and women no more than 1 alcoholic beverage per day 
 
CONCLUSIONS 
The results of this study support the hypothesis that a positive association exists between 
the performance of some diabetes mellitus self-management behaviors and the receipt of the 
ADFSE among the US population with diabetes mellitus.  The daily performance of SMBG and 
self-foot checks, receipt of the pneumococcal vaccination, and performance of resistance training 
at least two days per week were all significant and positively associated with the performance of 
the ADFSE.  In contrast, a negative association between receipt of the ADFSE and those who 
avoid excessive alcohol.  While this association is opposite of that found among the other 
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significant self-management behaviors, it may be explained by the development of PN among 
those who consume excessive alcohol, providing a different trigger for a foot inspection (97).   
We also found some associations between self-management behaviors and receipt of the 
ADFSE were modified by status of insulin use and receipt of formal diabetes mellitus education.   
Our results are consistent with findings from prior literature (65, 93, 94).  In the early 2000s 
national estimates from BRFSS data demonstrated the receipt of the ADFSE varied among sub-
population based on both insulin use and receipt of formal education (93).  In this study, the rates 
of performance of the ADFSE were higher among those who used insulin compared to those 
who did not use insulin as well as among those who received formal diabetes mellitus education 
compared to those who did not.  Rates of performing self-management behaviors were also 
higher in the sub-populations that used insulin and received formal education.  Among Asian-
Americans with diabetes mellitus use of insulin was also found as an effect modifier (65).  Those 
who use insulin in the Asian-American population were more likely to receive preventive care 
processes, including the ADFSE, compared to those who did not use insulin.  Given the 
consistency of effect in this study and other literature, it is apparent that future research should 
continue to explore the underlying causes for such variations and develop effective intervention 
programs that target at the subgroups of patients who are currently not benefiting from the 
ADFSE. 
Given the ADFSE is intended to prevent DFUs and, ultimate, LEAs, it is important to 
consider if the diabetes mellitus self-management behaviors found to be associated with the 
performance of the ADFSE in this study, also influence the rates of DFUs and LEAs in the US.  
A 2014 study conducted by Margolis, et al. found LEA rates in the US may be explained, in part, 
by variations in patient health behaviors, including diabetes mellitus self-management behaviors 
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and receipt of cancer screenings (92).  Our results indicate that performance of some diabetes 
mellitus self-management behaviors, may influence the performance of the ADFSE.  It is 
possible that the ADFSE is a link between the self-management behaviors and the lower rates of 
LEAs.  However, as proposed by Margolis, et al. our results may also be an indication of the 
level of health literacy among patients with diabetes mellitus.  Patients with diabetes mellitus 
that have a higher level of health literacy are more likely to complete recommended self-
management behaviors and gain more benefit from healthcare interventions (98, 99).  Thus, it is 
possible, that those with higher health literacy ensure the receipt of the ADFSE and follow DFU 
prevention recommendations resulting in lower rates of LEAs.  Further research is needed to 
assess the role health literacy plays in DFU and LEA prevention and management.   
As with other observational studies, this study is limited by the self-reported nature of the 
data which may introduced of recall, misclassification and possibility social desirability biases.  
The cross sectional nature of the data also limits the determination of causality.  One major 
limitation is the survey question utilized to define this study’s outcome measure.  The 
comprehensive ADFSE involves multiple components including a neurologic and vascular exam 
as well as visual inspection of the feet.  The BRFSS question only asks “has a health professional 
checked your feet for any sores or irritations?”  This implies a visual exam was completed but 
there is no indication if the neurologic and vascular exams were completed.  Thus, the outcome 
may be an overestimation of the true rate of the complete clinical ADFSE (40).  Another major 
limitation is the inability to discern if a participant has T1DM or T2DM.  Given the differences 
in disease management these populations should be considered separately in future analyses (4).  
Prior research has also identified provider type can influence the performance of preventive 
health services but this data is not available in the BRFSS data (100-102). 
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 Despite these limitations, this was the first study, to our knowledge, to systematically 
explore the association between individual diabetes mellitus self-management behaviors and 
receipt of the recommended ADFSE using a large, population based data set representing a 
majority of US states.  Thus, it provides results that are generalizable to the US population with 
diabetes mellitus within the 38 states captured in the BRFSS Diabetes Mellitus Optional Module.  
The main outcome of this study, the performance of the ADFSE, is based upon the same BRFSS 
survey question utilized by Healthy People 2020 to report national rates of completion of the 
ADFSE increasing the external validity of our study (91).  Research has also found good 
agreement between self-report of the ADFSE on the BRFSS and chart audits increasing the 
internal validity (43, 103).   
In conclusion our study provides support to the Piette and Kerr conceptual model which, 
in part, considers the influence of patient self-management behaviors on the clinical care of 
patients with diabetes mellitus.  We found that five diabetes mellitus self-management behaviors 
are positively associated with the performance of the ADFSE, an effective and cost-effective 
screening exam that is known to reduce DFUs and LEAs.  Future research must focus on 
demonstrating a causal relationship among diabetes mellitus self-management behaviors, 
performance of the ADFSE and ultimately, the prevention of DFUs and LEAs in the US 
population with diabetes mellitus.  If this causal relationship can be proven, existing programs 
aimed at improving self-management in patients with diabetes mellitus, such as Lifestyle 
Redesign® with an occupational therapist, could offer a solution to the problem of DFUs and 
LEAs (104).  The reduction of DFUs and LEAs in the ever increasing US population with 
diabetes mellitus would improve the quality of life of patients and reduce the financial burden on 
both patients and the US healthcare system.   
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CHAPTER 4: The Association Between Comorbidities and the Performance of the 
Recommended Annual Diabetes Foot Screening Examination 
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ABSTRACT 
Objective: This study aimed to assess the simultaneous, direct effects of concordant and 
discordant comorbidities on the performance of the annual diabetes foot screening exam 
(ADFSE), using structural equation modeling (SEM), to simulate clinical decision making. 
Research Design and Methods: We used the 2015 BRFSS data from 38 states (n=20,882) to 
conduct a cross-sectional study.  Respondents who provided a valid response regarding receipt of 
the ADFSE and had at least one visit to a health care provider in the past 12 months were 
included.  SEM was used to assess the simultaneous, direct effects of concordant and discordant 
comorbidity loads on the performance of the ADFSE.   
Results: In 2015, 78.2% of patients with diabetes received the ADFSE.  Hypertension (71.0%) 
was the most commonly and renal disease (8.2%) was the least commonly reported 
comorbidities.  On average, patients with diabetes have 4.8 comorbidities.  The final SEM model 
demonstrated that neither concordant comorbidities (β=0.226, p=0.086) nor discordant 
comorbidities (β=0.080, p=0.415) had a direct association with the performance of the ADFSE.   
Conclusions: The burden of concordant and discordant comorbidities are not associated with the 
performance of the ADFSE.  This may be a reflection of recent changes in the US healthcare 
system, such as the introduction of clinical practice guidelines and incentive payments for quality 
of care, including the performance of the ADFSE in the US population with diabetes.  However, 
in light of the burden DFUs and LEAs place on patient quality of life and the financial burden on 
the US healthcare system, identification of other influential factors and development of 
interventions to increase the rate of the ADFSE in the US may be the only way to reduce the 
rates of DFUs and LEAs in the US and the world.   
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INTRODUCTION 
The management of patients with DFUs costs the American health care system $9-13 
billion dollars annually and significantly increases utilization of emergency, inpatient and 
outpatient medical services (15).  When treatment fails patients must undergo an LEA, with more 
than 85% of all amputations in the US being preceded by a DFU (21).  With the prevalence of 
diabetes expected to increase and affect 21-34% of the US population by 2050, and the lifetime 
incidence of a DFU in this population as high as 34%, the costs of DFU management and rates of 
LEAs will likely increase (3, 23).  However, evidence has shown that up to 75% of DFUs and 
more than 49% of LEAs are preventable through cost-effective, comprehensive screening exams 
and prevention programs (31, 32).  It is essential that all individuals with diabetes receive the 
recommended ADFSE  (33, 36).   Despite the known benefits, in 2015, only 71.6% of the US 
population with diabetes received the ADFSE (88).   
The management of patients with diabetes includes 11 recommended preventive care 
processes, including the ADFSE, that are now a incorporated in quality of care processes 
measures in the US (105, 106).  Table 1 presents the 11 recommended diabetes care processes 
and the reported rates of completion in the US in 2015.  However, the medical management of 
patients with diabetes is further complicated by the presence of other comorbidities. Therefore, 
quality of care for patients with diabetes must also consider the management of comorbidities. .  
As discussed in the Piette and Kerr conceptual framework on competing demands of chronic 
comorbid conditions in diabetes care the need to complete diabetes care processes, including the 
ADFSE, competes with the need to complete self-management and clinical screenings for other 
comorbidities (50).  Within the time of an often brief clinical visit, health care providers must 
prioritize required preventive care processes along with management of patient comorbidities 
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and other patient reported symptoms.  Often the care of more complex or serious medical 
conditions, such as cancer, renal failure or symptomatic depression, preclude the performance of 
preventive care, such as the ADFSE (50).   
Table 4-1- Recommended diabetes preventive care processes and Healthy People 2020 reported results(62, 
105, 106) 
Preventive care process Healthy People 2020 
report year 
US diabetes 
population receiving 
preventive care 
process 
HgbA1c measurement at least twice a year 2007 64.8% 
LDL cholesterol measurement every 1-2 years NR* NR* 
At least annual blood pressure measurement NR* NR* 
Annual urinary microalbumin measurement 2012 42.4% 
Annual diabetes foot examination 2007 70.2% 
Annual dilated eye examination 2008 53.4% 
Annual dental examination 2014 54.5% 
Annual flu vaccination NR* NR* 
Annual pneumococcal vaccination NR* NR* 
Hepatitis B vaccination series NR* NR* 
Annual evaluation of footwear NR* NR* 
* NR- no report: not included in Healthy People 2020 or not specifically reported for diabetes population 
 
A majority of patients with diabetes must also manage at least one other chronic 
comorbid medical condition, such as hypertension or CAD (66). National estimates, published in 
2014, indicate that amongst those with diabetes in the US, nearly 85% were overweight or obese, 
57% had hypertension and over 58% had hypercholesterolemia.  In those aged  35 and over with 
diabetes, CAD and MI affect nearly 22%, while over 9% have suffered a CVA (67).  A study 
from 2015 reported nearly 90% of patients with diabetes had at least one other comorbidity 
(107).  The study also reported 37% of patients with diabetes had one to two other comorbidities 
while 43% had three to four.  Given these high rates of comorbidities and multiple concurrent 
comorbidities, it is imperative to understand how they compete with diabetes quality of care, in 
particular, the ADFSE. 
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Prior research has explored the relationships between individual comorbidities or the total 
number of comorbid conditions with the performance of a number of the recommended diabetes 
preventive care processes.  Studies have found individual comorbidities have differential effects 
on diabetes preventive care processes (55, 70).  A study utilizing a total count of comorbidities 
found patients with more than five comorbidities had an increased odds of receiving HgbA1c 
testing and annual dilated eye exams (68).  Piette and Kerr introduced a system to classify 
comorbidities as either concordant or discordant with diabetes disease management and 
preventive care processes (50).  Using this classification scheme studies have again found 
differential effects on recommended diabetes preventive care processes (52, 71). While studies 
demonstrated both positive and negative associations between individual comorbidities and total 
number of comorbidities, to date, no US study has explored the relationship between 
comorbidities and the ADFSE.   
 Thus far, the literature has suggested that the counts, individual comorbidities, and types 
of comorbidities may all exert an influence on the performance of some of the recommended 
diabetes preventive care processes.  There is also a lack of research among the US population 
exploring the relationship between comorbidities and the ADFSE.  Thus, we proposed to address 
this gap in the literature for the ADFSE while considering the number and types of 
comorbidities, as well as the individual contribution of specific comorbidities to simulate the 
clinical decision making process.  Health care providers must consider comorbidity 
interrelatedness, or the interaction of medical conditions and treatments, when conducting 
clinical exams (108). Therefore, this study aimed to assess the simultaneous, direct effects of 
concordant and discordant comorbidities on the performance of the ADFSE, using structural 
equation modeling (SEM), to simulate clinical decision making.   
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RESEARCH DESIGN AND METHODS 
Data Source and Sample 
 This study utilized data from the 2015 BRFSS (81).  The BRFSS is an annual cross-
section survey, administered by the CDC that interviews non-institutionalized US residents, over 
the age of 18. The BRFSS is designed to collect data on preventive health practices, health risk 
behaviors, and chronic disease that affect the US adult population.  The methods for sample 
design and sampling weighting to account for complex sample design are described elsewhere 
(82). 
The 2015 BRFSS included an option module focused on diabetes which included 10 
questions specific to diabetes care.  In 2015, the 38 states that participated in the Diabetes 
Optional Module included: Arizona, California, Colorado, Connecticut, Delaware, District of 
Columbia, Florida, Georgia, Hawaii, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, 
Maryland, Michigan, Minnesota, Montana, Nebraska, Nevada, New Hampshire, New Jersey, 
New Mexico, New York, North Carolina, Oklahoma, Pennsylvania, Rhode Island, South 
Carolina, Tennessee, Texas, Vermont, Utah, Virginia, Washington, Wisconsin, Wyoming.  This 
module was administered to all respondents, in participating states, who answered “yes” to the 
question “Has a doctor, nurse or other health professional every told you that you have 
diabetes?” in the BRFSS core component.  Respondents indicating the diagnosis of gestational, 
borderline or pre-diabetes were excluded from the Diabetes Optional Module in the BRFSS 
survey design.  A total of 36,085 of the 2015 BRFSS participants were eligible to participate in 
the Diabetes Optional Module.  
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 The inclusion criteria for this study required respondents have at least one foot, have had 
at least one visit to a health care provider for diabetes specific care within in the past 12 months 
and provided valid responses to all exposure and confounding variables.  The BRFSS contains a 
question requesting respondents indicate “About how often do you check your feet for any sores 
or irritations?” (90).  Those who gave a response of “no feet” (n=349) were excluded from the 
analytic sample.  The question “About how many times in the past 12 months have you seen a 
doctor, nurse or other health professional for your diabetes?” was utilized to identify all 
respondents who had at least one visit to a healthcare provider for diabetes care.  Those who 
reported having no visits or did not provide a valid response to this question were excluded from 
the analytic sample (n=3,656).  Finally respondents who did not provide valid answers to all 
exposure and confounding variable questions were also excluded (n=11,198).  The final analytic 
sample size for this study was 20,882.   
 
Measures 
The ADA and the IWGDF recommend patients with diabetes receive the ADFSE at least 
one time per year and this was defined as the outcome for this study (33, 36).  The outcome was 
operationalized using the BRFSS question “About how many times in the past 12 months has a 
health professional checked your feet for any sores or irritations?”  The respondents provided the 
number of times, on a continuous scale from 1-76, or “none.”  The responses were dichotomized, 
for this study, to “at least one ADFSE” and “none.”   
The main exposures of this study are two latent variables, “diabetes concordant 
comorbidity burden” and “diabetes discordant comorbidity burden.”  These latent variables are 
measured by observed variables for individual comorbid medical conditions.  The 2015 BRFSS 
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contains information on the diagnoses of hypertension, high cholesterol, MI, CAD, CVA, 
asthma, cancer, pulmonary diseases, orthopedic conditions, depressive disorder, renal disease, 
diabetic retinopathy and overweight or obese.  The assignment of indicators, the individual 
comorbidities, to each of the latent variables will be based upon the classifications from a Delphi 
study by Magnan et al. from 2015 (53).  The concordant comorbidities will be defined by 
indicators for the presence or absence of hypertension, high cholesterol, MI, CAD, CVA, renal 
disease, retinopathy and overweight or obese.  The discordant comorbidities will be defined by 
indicators for asthma, respiratory diseases, cancer, orthopedic diseases, and depressive disorders.   
The indicator for hypertension was derived from the survey question “have you ever been 
told by a doctor, nurse or other health professional that you have high blood pressure?” (90).  
Respondents answering “yes” were categorized as having hypertension.  For consistency with 
prior studies, female respondents indicating hypertension only during pregnancy and all 
respondents indicating “borderline high” or “pre-hypertension” will be categorized as not having 
hypertension (109-111).   
All cancer diagnoses, including skin cancer, were combined into one variable, consistent 
with the results of a Delphi study conducted by  Magnan, et al. (53).  Respondents answering 
“yes” to either “have you ever been told by a doctor, nurse or other health professional that you 
had skin cancer?” or “Ever told you had any other types of cancer?” will be classified as having 
cancer.  Respondents answering “no” to both questions will be considered to never have had 
cancer. 
The BRFSS created variables to identify adults who currently have asthma and another 
which calculated BMI (90).    The variable to identify adults who have been told they currently 
have asthma categorized respondents as either “yes, currently have asthma” or “no.”  The 
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calculated variable for BMI was retained as a continuous variable for the analysis.  Respondents 
with calculated BMI equal to or more than 25.0 will be classified as overweight/obese.  
Respondents with BMI less than 25.0 will be classified as not overweight/obese.   
Finally, the indicators for high cholesterol, MI, CAD, CVA pulmonary diseases, 
orthopedic conditions, depressive disorder, renal disease and diabetic retinopathy were 
constructed from a series of questions with the stem “have you ever been told by a doctor, nurse 
or other health professional that you had [chronic condition]?” (90).  A response of “yes” to each 
condition was categorized as having the chronic condition and responses of “no” as not having 
the chronic condition.  The BRFSS question for pulmonary diseases included the diagnoses of 
chronic obstructive pulmonary disease (COPD), emphysema and chronic bronchitis.  The 
question for orthopedic conditions includes the diagnoses of rheumatism, polymyalgia 
rheumatica, osteoarthritis, tendonitis, bursitis, bunion, tennis elbow, carpal tunnel syndrome, 
tarsal tunnel syndrome and joint infections.   
Potential confounders for the study, based on prior research, included: respondents age 
(<65/≥65 years old), gender (male/female), race (White non-Hispanic, Black non-Hispanic, 
Hispanic, or other), education (did not graduate high school, graduated from high school , 
attended college or technical school, or graduated from college or technical school), marital 
status (married/member of an unmarried couple, divorced/separated, widowed or never married), 
annual household income (<$15,000, $15,000- <$25,000, $25,000- <$35,000, $35,000- 
<$50,000, ≥$50,000), insurance status (insured/uninsured), insulin use (yes/no) and receipt of a 
diabetes education course (yes/no) (47, 51, 52, 54, 55, 71).  
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Statistical Analysis 
 Descriptive statistics for the outcome, all exposures and potential confounders were 
calculated.  This included analyses stratified based on receipt of the ADFSE.  All proportions 
and means were weighted to provide population level estimates based on the complete sample 
design of the BRFSS. Chi-squared or student’s t-test were utilized to compare groups.   
 SEM methods, using the two step approach, were used to assess the simultaneous, direct 
effects each of the latent variables, concordant and discordant comorbidities, have on the 
performance of the ADFSE.  First, confirmatory factor analysis (CFA) was conducted to assess 
the goodness-of-fit of the measurement model.  A good model fit was defined by a root mean 
squared error of approximation (RMSEA) less than 0.05 and a Comparative Fit Index (CFI) 
greater than 0.95 (112).  If a CFA model was found to not be a good fit of the data, standardized 
solutions for between each indicator and the associated latent variable were calculated to 
determine the correlations.  Indicators with poor correlation (p<0.2) to the latent variable were 
removed from the model.  The reduced CFA model was then reanalyzed for goodness-of-fit.  
Once the measurement model demonstrated a good fit with the data, final correlations and 
variance explained by each indicator were determined.    
 Once an acceptable measurement model was determined through CFA, probit structural 
regression modeling was undertaken to assess the full model 1.  First, potential confounders were 
determined by calculating the odds ratio and 95% CI between each potential confounder and the 
outcome.  Confounders were included in the final model if the bivariate association was 
significant (p<0.05).  The final model, with confounders, was assessed using structural 
regression modeling.  Model goodness-of-fit was first assessed utilizing RMSEA less than 0.05 
and CFI greater than 0.95.   
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All analyses were conducted with adjustment for the complex sample design of the 
BRFSS.  Proportions and means represent national estimates and include standard error 
estimations (82).  Data analyses were generates using SAS version 9.4 (SAS Institute Inc., Cary, 
NC, USA) and MPlus version 9 (Muthén & Muthén, Los Angeles, CA, USA).   
 
RESULTS 
In 2015, 78.2% of the US population with diabetes and at least one visit to a health care 
provider for diabetes care reported receipt of the ADFSE.  The demographic characteristics of 
the total study population (n=20,882), and the study population stratified by receipt of the 
ADFSE, are presented in Table 2.  In 2015, a majority of the US population with diabetes were 
male (53.8%), under the age of 65 (59.6%), non-Hispanic white (58.9%) and were married or a 
member of an unmarried couple (61.7%).  A majority of the population reported at least some 
education at the college level (51.0%).  37.5% had an annual household income over $50,000.  
Over 93% of the population with diabetes reported having some form of health insurance 
coverage in 2015.  Only 33% reported using insulin and more than 58% reported receipt of 
formal diabetes education.   
Among those who received the ADFSE in 2015, 54.1% were male and 58.2% were under 
the age of 65.  When race was examined, those who received the ADFSE were 60.5% non-
Hispanic white, 16.7% non-Hispanic blacks, 14.8% Hispanic and 8.0% of other reported races.  
Of those who received the ADFSE 47.9% had less than high school level or had graduated high 
school while 52.1% had at least some college education, 48.4% earned less than $35,000 in 
annual household income, and 93.9% had some form of health insurance.  A majority of people 
who received the ADFSE were married or a member of an unmarried couple (61.7%), 17.1%  
49 
 
 
Table 4-2- Demographic characteristics of persons aged ≥18 years with diagnosed diabetes, 38 states* 
(n=20,882) 
 Population 
estimate 
 
 %           SE 
Received annual diabetes foot 
screening exam in past 12 months 
         Yes                          No      
    78.18±0.93%†       21.82±0.93%†         
     %           SE           %             SE            
P value‡ Bivariate 
analysis 
Odds ratio 
(95% CI) 
DEMOGRAPHIC CHARACTERISTICS 
Sex 
   Male 
   Female 
 
53.8 
46.2 
 
1.0 
1.0 
 
54.1 
45.9 
 
1.3 
1.3 
 
53.0 
47.0 
 
2.5 
2.5 
 
0.6991 
 
 
Ref 
1.04 (0.84-1.30) 
Age (years) 
   18-64 
   ≥65 
 
59.6 
40.4 
 
1.0 
1.0 
 
58.2 
41.8 
 
1.1 
1.1 
 
64.8 
35.2 
 
2.2 
2.2 
 
0.0095 
 
 
Ref 
0.76 (0.61-0.93) 
Race 
   Non-Hispanic white 
   Non-Hispanic black 
   Hispanic 
   Other 
 
58.9 
15.8 
16.9 
8.3 
 
1.1 
0.7 
1.0 
0.9 
 
60.5 
16.7 
14.8 
8.0 
 
1.0 
1.0 
1.0 
1.0 
 
53.5 
12.9 
24.2 
9.4 
 
2.2 
2.2 
2.2 
2.2 
 
0.0012 
 
Ref 
0.88 (0.67-1.15) 
1.85 (1.32-2.60) 
1.33 (0.76-2.33) 
Education 
   Less than high school 
   High school graduate 
   Some college 
   College graduate 
 
18.8 
30.2 
31.3 
19.7 
 
1.0 
0.9 
1.0 
0.8 
 
17.9 
30.0 
31.9 
20.2 
 
1.0 
1.0 
1.1 
0.9 
 
21.9 
30.7 
29.2 
18.2 
 
2.4 
2.2 
2.3 
1.6 
 
0.2316 
 
 
1.36 (0.95-1.94) 
1.14 (0.87-1.49) 
1.01 (0.76-1.35) 
Ref 
Marital status 
   Married/couple 
   Divorced/separated 
   Widowed 
   Never married 
 
61.7 
17.1 
11.7 
9.4 
 
0.9 
0.6 
0.5 
0.5 
 
61.7 
17.1 
11.9 
9.3 
 
1.0 
0.6 
0.5 
0.5 
 
61.8 
17.4 
10.9 
9.0 
 
2.2 
1.4 
0.9 
1.4 
 
0.8703 
 
Ref 
1.02 (0.81-1.29) 
0.91 (0.72-1.16) 
1.06 (0.76-1.49) 
Annual household income 
   <$15,000 
   $15,000-<$25,000 
   $25,000-<$35,000 
   $35,000-<$50,000 
    ≥$50,000 
 
15.5 
22.2 
11.8 
13.0 
37.5 
 
0.8 
0.9 
0.6 
0.5 
1.0 
 
15.3 
21.5 
11.6 
13.2 
38.4 
 
0.9 
0.9 
0.7 
0.6 
1.1 
 
16.3 
25.0 
12.6 
12.1 
34.0 
 
1.9 
2.4 
1.5 
1.2 
2.4 
 
0.2939 
 
1.21 (0.86-1.68) 
1.32 (0.97-1.79) 
1.23 (0.89-1.71) 
1.03 (0.78-1.37) 
Ref 
Health insurance 
   Yes 
   No 
 
93.4 
6.4 
 
0.6 
0.6 
 
93.9 
6.1 
 
0.7 
0.7 
 
92.4 
7.6 
 
1.4 
1.4 
 
0.3018 
 
Ref 
1.27 (0.81-2.00) 
Use insulin 
   Yes 
   No 
 
32.6 
67.4 
 
0.9 
0.9 
 
35.7 
64.3 
 
1.0 
1.0 
 
21.6 
78.4 
 
1.8 
1.8 
 
<0.0001 
 
Ref 
2.02 (1.60-2.54) 
Received diabetes 
education 
   Yes 
   No 
 
 
58.3 
41.7 
 
 
1.0 
1.0 
 
 
61.3 
38.7 
 
 
1.1 
1.1 
 
 
47.6 
52.4 
 
 
2.5 
2.5 
 
 
<0.0001 
 
 
Ref 
1.74 (1.40-2.16) 
* In 2015, the 38 states that participated in the Diabetes Optional Module included: Arizona, California, Colorado, 
Connecticut, Delaware, District of Columbia, Florida, Georgia, Hawaii, Illinois, Indiana, Iowa, Kansas, Kentucky, 
Louisiana, Maryland, Michigan, Minnesota, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New 
Mexico, New York, North Carolina, Oklahoma, Pennsylvania, Rhode Island, South Carolina, Tennessee, Texas, 
Vermont, Utah, Virginia, Washington, Wisconsin, Wyoming.   † Percentage of population ± SE. ‡ P-values from χ2 
test.   
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were divorced or separated from a spouse, 11.9% were widowed and 9.3% were never married.  
Finally, among those who received the ADFSE, 35.7% used insulin, 64.3% did not use insulin, 
61.3% received formal diabetes education and 38.7% did not receive formal education.   
 Examining those who did not receive the ADFSE, 53.0% were male and64.8% were 
under the age of 65.   Among those who did not receive the ADFSE, 53.5% were non-Hispanic 
white, 12.9% were non-Hispanic black, 24.2% were Hispanic and 9.4% were of other reported 
races.   A majority of people who received the ADFSE received at least some college level 
education (52.1%) and were married or a member of an unmarried couple (61.8%).  Of those 
who received the ADFSE, 53.9% had less than $35,000 in annual household income but 92.4% 
had health insurance.  Finally, among patients who did not receive the ADFSE, 21.6% used 
insulin and 47.6% had received formal diabetes education.  There were no statistically significant 
differences in the receipt of the ADFSE based on sex, education level, marital status, annual 
household income or health insurance status.   
Table 3 describes the comorbid conditions reported by person over the age of 18 with 
diagnosed diabetes.  The reports indicate the US population with diabetes have an average of 4.8 
comorbid conditions of which 2.9 are considered to be concordant and 1.9 are discordant for the 
purposes of this study.  Being overweight or obese is the most commonly reported comorbidity 
(86.8%) while renal disease is the least commonly reported comorbid condition (8.3%).  The 
proportion of the population with the remaining concordant comorbid conditions are: 64.4% 
have hypercholesterolemia, 13.3% reported a prior MI, 14.1% have CAD, 8.2% report a prior 
CVA, and 19.3% report retinopathy.  For the discordant comorbid conditions, the population 
reports 11.1% currently have asthma, 12.8% have COPD, 20.0% report a history of cancer, 
46.3% report an orthopedic condition and 23.3% report depression.   
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Table 4-3- Reported comorbid conditions in persons aged ≥18 years with diagnosed diabetes, 38 states* 
(n=20,882) 
  
Population estimate 
 
 
%                SE 
Received diabetes foot screening exam in  
past 12 months 
              Yes                                 No      
        78.18±0.93%†               21.82±0.93%†         
      %                SE                %                SE            
P value† 
CONCORDANT COMORBID CONDITIONS 
Hypertension 
   Yes 
   No 
 
71.0 
29.0 
 
1.0 
1.0 
 
72.2 
27.8 
 
1.1 
1.1 
 
66.5 
33.5 
 
2.7 
2.7 
 
0.0396 
 
Hypercholesterolemia 
   Yes 
   No 
 
64.4 
35.6 
 
1.1 
1.1 
 
64.6 
35.4 
 
1.1 
1.1 
 
63.6 
36.4 
 
2.6 
2.6 
 
0.7414 
 
Prior myocardial infarction 
   Yes 
   No 
 
13.3 
86.7 
 
0.6 
0.6 
 
13.8 
86.2 
 
0.6 
0.6 
 
11.6 
88.4 
 
1.2 
1.2 
 
0.1155 
Coronary artery disease 
   Yes 
   No 
 
14.1 
85.9 
 
0.7 
0.7 
 
15.0 
85.0 
 
0.8 
0.8 
 
10.8 
89.2 
 
1.1 
1.1 
 
0.0036 
Prior cerebrovascular 
accident 
   Yes 
   No 
 
8.2 
91.8 
 
0.6 
0.6 
 
8.1 
91.9 
 
0.6 
0.6 
 
8.6 
91.4 
 
1.3 
1.3 
 
0.7238 
Retinopathy 
   Yes 
   No 
 
19.3 
80.7 
 
0.8 
0.8 
 
20.5 
79.5 
 
0.9 
0.9 
 
15.1 
84.6 
 
1.5 
1.5 
 
0.0040 
Renal disease 
   Yes 
   No 
 
8.3 
91.7 
 
0.4 
0.4 
 
8.9 
91.1 
 
0.5 
0.5 
 
6.3 
93.7 
 
1.0 
1.0 
 
0.0455 
Overweight/obese 
   Yes 
   No 
 
86.8 
13.2 
 
0.6 
0.6 
 
86.8 
13.2 
 
0.7 
0.7 
 
86.8 
13.2 
 
1.4 
1.4 
 
0.9984 
DISCORDANT COMORBID CONDITIONS 
Current asthma 
   Yes 
   No 
 
11.1 
88.9 
 
0.5 
0.5 
 
11.4 
88.6 
 
0.6 
0.6 
 
9.9 
90.1 
 
1.2 
1.2 
 
0.2753 
 
Chronic obstructive 
pulmonary diseases 
   Yes 
   No 
 
 
12.8 
87.2 
 
 
0.7 
0.7 
 
 
13.5 
86.5 
 
 
0.8 
0.8 
 
 
10.2 
89.8 
 
 
0.9 
0.9 
 
 
0.0068 
Any cancer history 
   Yes 
   No 
 
20.0 
80.0 
 
0.8 
0.8 
 
19.4 
80.6 
 
0.8 
0.8 
 
22.5 
77.5 
 
2.1 
2.1 
 
0.1499 
Orthopedic issues 
   Yes 
   No 
 
46.3 
53.8 
 
1.0 
1.0 
 
46.3 
53.7 
 
1.1 
1.1 
 
46.4 
53.6 
 
2.4 
2.4 
 
0.9712 
Depression 
   Yes 
   No 
 
23.3 
76.7 
 
0.8 
0.8 
 
22.9 
77.1 
 
0.9 
0.9 
 
24.7 
75.3 
 
1.9 
1.9 
 
0.3726 
 
 Population mean 
  Mean             SE 
Received diabetes foot screening exam in  
past 12 months 
              Yes                                 No      
  Mean             SE             Mean             SE 
P value‡ 
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Total comorbid conditions 4.77 0.04 4.80 0.04 4.63 0.10 <0.0001 
Total concordant conditions 2.85 0.03 2.90 0.03 2.70 0.07 <0.0001 
Total discordant conditions 1.91 0.02 1.01 0.02 1.94 0.05 <0.0001 
 
Looking specifically at the population who received the ADFSE, they have an average of 
4.8 comorbid conditions with 2.9 concordant and 1.0 discordant condition.  Overweight or obese 
status (86.8%) remains the most common comorbid condition and renal disease (8.9%) remains 
the least common comorbid condition reported.  The remaining concordant medical conditions 
are reported at rates of: 64.6% for hypercholesterolemia, 13.8% reported having a prior MI, 
15.0% report CAD, 8.1% report prior CVA, and 20.5% reported retinopathy.  Among the 
discordant medical conditions, those who received the ADFSE reported rates of: 11.4% for 
having current asthma, 13.5% report having COPD, 19.4% report a history of cancer, 46.3% 
have an orthopedic condition and 22.9% report depression.   
Among those that did not receive the ADFSE, the study population reported an average 
of 4.6 comorbid conditions of which an average of 2.7 are concordant conditions and an average 
of 1.9 are discordant conditions.  The proportions of concordant comorbid conditions of the 
study population who did not receive the ADFSE are: 66.5% with hypertension, 63.6% have 
hypercholesterolemia, 11.6% report a prior MI, 10.8% have CAD, 8.6% report a prior CVA, 
15.1% have retinopathy, 6.3% have renal disease and 86.% are overweight or obese.  Discordant 
comorbid conditions are reported at rates of 9.9% with current asthma, 10.2% with COPD, 
22.5% have a history of cancer, 46.4% report an orthopedic condition and 24.7% have 
depression and did not receive the ADFSE.   
The final CFA model demonstrated a good fit between the proposed model and the 
observed data based on an RMSEA of 0.011 (90%CI: 0.009-0.013) and a CFI of 0.959.  
Standardized and unstandardized parameter estimates are presented in Table 4.   The proportion 
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of the latent factor variance explained by each indicator is also included in Table 4.  None of the 
indicators for concordant comorbidities had a variance greater than 37% explained by the latent 
factor.  For discordant comorbidities, only COPD (59.3%) had over half of its variance explained 
by the latent factor.  This indicates poor convergent validity between the indicators and latent 
factors.  
Table 4-4- Unstandardized coefficients, standardized coefficients and percentage of variance explained for 
the final CFA model.   
Indicator Latent variable Unstandardized 
coefficient (B) 
Standardized 
coefficient (β) 
Percentage of 
variance explained 
Hypertension Concordant 1.00 0.59±0.04 34.8 
Hypercholesterolemia Concordant 0.73±0.08 0.43±0.04 18.5 
Myocardial infarction Concordant 0.88±0.09 0.52±0.04 27.0 
Coronary artery 
disease 
Concordant 1.06±0.09 0.62±0.03 38.4 
Prior cerebrovascular 
accident 
Concordant 0.87±0.08 0.51±0.03 26.0 
Renal disease Concordant 0.87±0.08 0.51±0.03 26.0 
Retinopathy Concordant 0.59±0.07 0.34±0.04 11.6 
Current asthma Discordant 1.00 0.57±0.04 32.5 
Chronic obstructive 
pulmonary diseases 
Discordant -1.35±0.15 -0.77±0.06 59.3 
Orthopedic disease Discordant -1.05±0.08 -0.60±0.03 36.0 
Depression Discordant -0.97±0.07 -0.55±0.03 30.3 
 
The final SEM model, presented in Figure 1, demonstrated a good fit between with the 
observed date.  The model fit statistics were: χ2=(df=93)=645.238, p<0.0001, RMSEA=0.017 
(90%CI: and CFI=0.807.  Given a low CFI value the null model RMSEA was examined and 
found to be 0.0346.  The low null model RMSEA (<0.158) indicates the CFI is not informative 
for this model (113).   Table 4 presents the unstandardized probit estimates (β), SEs, and p-
values for regression pathways of the final SEM model.  After controlling for age, race, insulin 
use and receipt of formal diabetes education the direct effects of concordant comorbidities 
(β=0.226, p=0.086) and discordant comorbidities (β=0.080, p=0.415) on the performance of the 
ADFSE were not significant. Thus, neither concordant nor discordant comorbidities significantly 
contribute to the probability that the ADFSE is performed.   
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  Figure 4-1- Final SEM model.  RMSEA=0.017, null model RMSEA=0.035. 
 
 
  Solid pathways indicate statistically significant model pathways.  Dashed pathways indicate non-significant   
  pathways.  HTN – hypertension.  HCL-hypercholesterolemia.  MI- myocardial infarction.  CAD-coronary artery  
  disease.  CVA-cerebrovascular accident.  Renal- renal disease.  COPD- chronic obstructive pulmonary disease.    
  Ortho-orthopedic conditions.  ADFSE- annual diabetes foot screening exam. 
 
 
Table 4-5- Unstandardized estimates (β), standard error (SE) and p-values for regression pathways of the 
final SEM model.   
Pathway 
Unstandardized 
coefficient (β) 
SE P-value 
Concordant comorbidities → 
ADFSE 
0.23 0.13 0.09 
Discordant comorbidities → 
ADFSE  
0.08 0.10 0.42 
Race → ADFSE -0.09 0.04 0.02 
Age → ADFSE 0.154 0.06 0.02 
Insulin use → ADFSE 0.35 0.07 <0.0001 
Diabetes education → ADFSE 0.27 0.6 <0.0001 
 
CONCLUSIONS 
 The current findings of this study indicate that there are no simultaneous, direct 
associations between concordant nor discordant medical comorbidities and the performance of 
55 
 
the ADFSE.  These results may suggest that the competing demands of chronic comorbid 
conditions in diabetes care have little influence on the decision of a health care provider to 
perform the ADFSE. Our results are similar to two international studies which also demonstrated 
no association between concordant and discordant conditions and the performance of the ADFSE 
(72, 73). 
 However, our results differ from US studies conducted in the mid-2000s through 2011.  
While the ADFSE was not included in the studies, researchers found that increasing numbers of 
total comorbidities and concordant comorbidities improved performance of some diabetes 
quality care processes while discordant conditions reduced performance of at least one care 
process (52, 54, 68).  To understand the difference between these results and those of these prior 
US studies, one must consider the full conceptual model of Piette and Kerr, including the role of 
healthcare organizations the management of patients with diabetes (50).  Healthcare 
organizations place controls on clinical care, such as clinical practice guidelines and 
reimbursement strategies that directly influence how health care providers prioritize care in the 
clinical environment.  In 1995, the ADA, the Centers for Medicare and Medicaid Services 
(CMS) and the National Committee on Quality Assurance introduced the Diabetes Quality 
Improvement Program (DQIP) which included eight process and outcomes measures (114).  The 
DQIP program was adopted by CMS, the Veterans Health Administration (VHA) and other 
commercial health plans and some progress was made toward improving diabetes quality of care.  
The studies which found associations between concordant and discordant conditions and diabetes 
quality of care were conducted while the DQIP was being utilized (52, 54, 68).  Our study, 
utilized data that was collected after the initiation of the CMS Physicians Quality Reporting 
Initiative (PQRI) was begun in 2009.  The PQRI program was introduced to improve overall 
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quality of care in the US and began the transition from fee-for-service to a pay-for-performance 
reimbursement model in the CMS patient populations (115).  Health care providers are 
financially incentivized, through a reward and penalty system, for addressing pre-defined quality 
care measures, including the ADFSE for patients with diabetes (106).  These financial incentives 
for the Medicare and Medicaid populations, may explain the null findings of this study which 
were based on data collected in 2015.  Given the null findings included people with insurance 
other than Medicare and Medicaid, our results may be a reflection of a shift in clinical practice 
toward preventive care. 
 Another possible explanation for our null findings was the use of dichotomous indicators 
for the comorbidities.  While the CFA model demonstrated a good fit with the data, there was 
poor convergent validity between the indicators and the latent factors defined in this study.  The 
use of dichotomous variables limits the ability to define the severity and level of control of a 
disease.  Disease severity, level of control and patient symptoms may influence the performance 
of screening exams, such as the ADFSE, during clinic visits and should thus be considered in 
research (108).  Future research using clinical measures of severity and disease control, such as 
blood pressure measurements rather than a dichotomous indicator for presence of hypertension, 
may help increase convergent validity and thus improve final model fit.  However, the issue of 
convergent validity may also be an indication that our proposed latent variables of concordant 
and discordant comorbidities are not a good statistical representation of the concept of 
comorbidity interrelatedness.  A 2018 study by Magnan, et al. utilized exploratory factor analysis 
to stratify patients by clusters of chronic conditions (116).  All five of the clusters explored 
increased the odds that diabetes preventive care processes were performed.  However, the 
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ADFSE was not included.  This and other statistical models will need to be explored in future 
research.   
 Despite these potential issues with the statistical model, our study has many notable 
strengths.  First, it is the first study to utilize a large, nationally representative sample to explore 
the simultaneous relationship between types of comorbidities and the performance of the 
ADFSE.  Second, the use of SEM methods allows for the assessment of the simultaneous effects 
of comorbidities that are concordant and discordant with diabetes care, while accounting for 
demographic and other characteristics.  This is an improvement from prior studies that used 
statistical models that could only address count or category of comorbidity.  Health care 
providers rarely have the luxury to consider each comorbidity in isolation and thus models which 
address only count or individual comorbidities  are not an ideal representation of the clinical 
decision making process.  Our model introduced, to a degree, the comorbidity interrelatedness 
that health care providers must consider in all clinical decision making processes (108).   
 While the use of a large, national data set was a strength of this study, the use of the 
BRFSS and the cross-sectional study design have additional limitations.  First, the BRFSS is 
based on self-report and this may introduce recall, misclassification and social desirability bias 
into the results.  The BRFSS also does not differentiate between individuals with type 1 diabetes 
and type 2 diabetes.  Given the differences in disease etiology, medical management strategies 
and comorbidity profiles for these two populations, it would be prudent to explore the 
populations separately, but this is not possible with BRFSS (4).  In addition, the BRFSS does not 
contain measures of severity for diabetes nor for the other comorbidities explored in this study.  
Both Piette and Kerr and Zulman, et al. suggested disease severity be included in the 
understanding of diabetes management (50, 108).  Conditions that are controlled, or require 
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minimal management, may not influence the performance of the ADFSE and result in 
overestimation of the contribution of a comorbidity.  However, if a condition is dominant or 
severe, such as active cancer or end-stage COPD, the patient and health care provider may opt to 
forgo diabetes screenings to focus on the dominant condition.  Unfortunately, the 2015 BRFSS 
does not contain data on disease severity.  This lack of information could result in inaccurate 
estimates of the association between comorbidities and the ADFSE.   
 Given the current and potential future burden of DFUs and LEAs on the US population 
with diabetes and the burden on the US healthcare system it is important to understand the 
factors that influence the performance of the ADFSE.  Our study gives an indication there may 
be a shift occurring the US health system where factors other than patient level comorbidities are 
influencing the performance of this cost-effective and efficient screening exam for the population 
with diabetes.  The Piette and Kerr conceptual model includes the influence of healthcare 
organizations as well as health care provider’s resources and priorities in care.  It will be 
important to explore all of these factors simultaneously with patient level factors and priorities in 
future research on the ADFSE and other diabetes preventive care processes.  It is predicted that 
more than 64 million Americans will have diabetes in 2050 and up to 34%, or 21 million people, 
will have a DFU during their lifetime (3, 23).  Given the high cost of care and impact on patient 
quality of life, DFUs and LEAs must be reduced in the US population with diabetes.  
Identification of influential factors and development of interventions to increase the rate of the 
ADFSE to 100% in the US may be the only way to reduce the rates of DFUs and LEAs in the US 
and the world.   
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CHAPTER 5: The Associations Between Visit Frequency and Competing Demands on the 
Performance of the Recommended Annual Clinical Diabetic Foot Screening 
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ABSTRACT 
Objective: This study to examine the relationship between the performance of other diabetes 
preventive care processes, the number of office visits for diabetes care and the completion of the 
annual diabetes foot screening exam (ADFSE). 
Research Design and Methods: We used the BRFSS data from 38 states (n=19,056) to conduct a 
cross-sectional study.  Respondents who provided a valid response regarding receipt of the 
ADFSE and had at least one visit to a health care provider in the past 12 months were included.  
Structural equation modeling was used to assess the simultaneous, direct effects of the 
performance of other diabetes preventive care processes and the number of office visits for 
diabetes care on the completion of the ADFSE.   
Results: In 2015, 80.4% of the US population received the ADFSE.  On average, patients with 
diabetes received 3.9 diabetes preventive care processes.  The collection of preventive care 
processes demonstrated a 7% (OR: 1.07, 95%CI: 1.05-1.10) increase in the likelihood the 
ADFSE was performed for each unit increase in processes performed.  The number of visits to a 
healthcare provider for diabetes care was found to have a non-significant association with the 
ADFSE (OR=1.00, 95%CI=1.00-1.00, p=0.56).   
Conclusions: The completion of increasing numbers of diabetes preventive care processes are 
positively associated with the performance of the ADFSE.  This may be due, in part, to the recent 
implementation of electronic medical records and financial incentives to healthcare providers to 
improve overall quality of care in the US healthcare system.  Further, research should continue to 
explore other approaches which may positively influence the completion of the ADFSE and help 
reduce the development of DFUs in the US population.  
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INTRODUCTION 
More than one-third of the cost of care for patients with diabetes, over $38 billion, in the 
US is a result of management of DFUs (117).  The cost of managing a patient an active DFU is 
estimated to be  $28,000-$31,000 annually, nearly twice as much as those who have diabetes 
alone (15).  When a DFU fails to heal, the ultimate consequence for a patient is LEA.  Between 
2007 and 2010, up to 5% of patients with diabetes underwent an LEA to resolve a non-healing 
DFU (15).  Despite medical advances in wound care, the 5-year mortality rate for patients with a 
DFU or a LEA is between 45% and 72% (28, 86).  However, cost effective ADFSE and patient 
education prevention programs can prevent up 75% of DFUs and 85% of LEAs (31, 32).  
Despite the benefits of performing the ADFSE, less than three-quarters of the US population 
with diabetes received this life-saving screening exam in 2015 (88). 
 The ADFSE is one of 11 recommended preventive care processes endorsed by the ADA 
and CMS which should be performed at least annually for patients with diabetes (114).  Between 
2009 and 2012, 86% of the population with diabetes underwent blood cholesterol testing but 
only 50% received the recommended twice annual HgbA1c blood test (118).  Historically, 
provision rates of these preventive care screening processes remain suboptimal due to competing 
demands.  These competing demands including such as provider preferences and expertise, visit 
length and, patient concerns, financial constraints and comorbidities (74, 77, 101, 102).  The 
Piette and Kerr conceptual model explores competing demands for diabetes care  and presents 
“diabetes medical management” as one factor that has direct influence on diabetes care (50).  
While research has explored competing demands from concurrent comorbidities, little is known 
about the influences of the frequency of outpatient visit for diabetes care and other diabetes 
preventive care processes on the performance of the ADFSE (52, 54, 55, 71) .   
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Prior research has demonstrated two to four health care visits per year increased the 
likelihood that diabetes preventive care processes, such as HgbA1c testing and retinal exams, 
were completed (41, 65, 76, 80).  That same frequency of visits to a health provider increased the 
odds the ADFSE was performed (41, 65, 76).  A 2005 study demonstrated that performance of 
mammograms and Pap smears increased significantly as the number of completed diabetes care 
processes increased (79).  To date, no studies have addressed the influence of both the patient 
visits frequency and clinical competing demands on the performance of the ADFSE.  Thus, this 
study aims to examine the relationship between the performance of other diabetes preventive 
care processes, the number of office visits for diabetes care and the completion of the ADFSE. 
 
RESEARCH DESIGN AND METHODS 
Data Source and Sample 
 This study used data from the 2015 BRFSS, an annual, cross-sectional survey conducted 
by the CDC (81).  The BRFSS surveys non-institutionalized US residents, over the age of 18 
years, to collect information on preventive health care practices, health risk behaviors, chronic 
diseases, injuries and preventable infectious diseases that affect the US adult population.  The 
methods for sample weighting to account for the complex sample design are described elsewhere 
(82). 
  In 2015, 38 states participated in the BRFSS Diabetes Optional Module which contained 
10 questions specific to diabetes specific self-management activities and recommended 
preventive care processes.  Survey respondents who answered “yes” to the question “Has a 
doctor, nurse or other health professional every told you that you have diabetes?” were included 
in the sample eligible to participate in the Diabetes Optional Module (n=36,085).  Respondents 
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with “pre-diabetes,” “borderline diabetes,” and “gestational diabetes” were excluded from 
participation in the Diabetes Optional Module. 
 Inclusion in this study also required respondents to have at least one foot, at least one 
visit to a health care provider for diabetes care in the past 12 months and provide valid responses 
to all outcome, exposure and confounder variables.  Respondents with no feet (n=328) were 
identified by the answer of “no feet” to the survey question “About how often do you check your 
feet for any sores or irritations?”  Having at least one visit to a health provider for diabetes care 
in the past year was determined utilizing the question “About how many times in the past 12 
months have you seen a doctor, nurse or other health professional for your diabetes?”  
Respondents reporting no visits, “don’t know/not sure” and those who refused to answer the 
question were excluded from the study sample (n=4,121).  Finally, an additional 12,580 
respondents were excluded from the study sample due to invalid responses to the outcome, 
exposure and confounding variables.  The final study sample size was 19,056. 
 
Measures  
The primary outcome of this study was defined as having at least one ADFSE in the past 
12 months.  The 2015 BRFSS Diabetes Optional Module asks “About how many times in the 
past 12 months has a health professional checked your feet for any sores or irritations?”  
Responses were continuous between 1 and 76, “none,” “don’t know,” or refused to answer.  The 
responses were dichotomized to “yes, at least one time” or “no.”  Respondents providing answers 
of “don’t know” or those who refused to answer were be considered “missing” and excluded 
from the data analysis. 
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This study’s main exposure variables included the number of visits to a health care 
provider for diabetes care and a latent variable to represent the competing demands of diabetes 
preventive care processes.  The 2015 BRFSS collected information on five of the recommended 
processes which included: HgbA1c and cholesterol blood tests, retinal exams, and receipt of 
influenza and pneumonia vaccinations.  The number of visits for diabetes care was 
operationalized using the questions “About how many times in the past 12 months have you seen 
a doctor, nurse or other health professional for your diabetes?”  Responses were reported as a 
continuous number of visits for diabetes care (1-76 visits) or no visits and were retained as a 
continuous variable in the statistical model.   
The five preventive care processes were defined based on frequency recommendations by 
the ADA (4, 33, 119, 120).  Responses to the question “About how many times in the past 12 
months has a doctor, nurse, or other health professional checked you for “A one C”?” were 
dichotomized to “at least 2 HgbA1c tests per year” and “less than 2 HgbA1c tests per year.”  The 
2015 BRFSS asks respondents “Have you EVER had your blood cholesterol checked?”  
Participants who respond “no” were classified as “not adherent to cholesterol screening 
guidelines.”  For those who answered “yes” to this questions, the follow-up question “About how 
long has it been since you last had your blood cholesterol checked?” was asked.  Respondents 
answering “in the last year” and “in the last 2 years” were categorized as “yes, adherent to 
cholesterol screening guidelines.”  Those who responded “in the last 5 years” or “5 or more years 
ago” were categorized at “not adherent to cholesterol screening guidelines.”  Adherence to the 
recommendation for comprehensive eye exams was determined by the question “When was the 
last time you had an eye exam in which the pupils were dilated?”  Responses of “in the past 
month,” “in the past year,” and “in the past 2 years” were dichotomized to “yes, adherent with 
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recommended retinal exams.”  Respondents indicating “2 or more years ago” and “never” were 
dichotomized to “no, not adherent with recommended retinal exams.”  Receipt of an annual 
influenza and pneumococcal vaccinations, were determined by the question “During the past 12 
months, have you had either a flu shot or a flu vaccine that was sprayed in your nose?” and 
“Have you ever had a pneumonia shot?”  The BRFSS collected “yes” and “no” responses and no 
recoding was required.   
Potential confounders for this study were based on prior studies and included: gender 
(male or female), respondent age (<65 year or  ≥65 years), race (White non-Hispanic, Black non-
Hispanic, Hispanic, or other), education (did not graduate from high school, graduated from high 
school , attended college or technical school, or graduated from college or technical school), 
marital status (married, divorced, widowed or never married), annual household income 
(<$15,000, $15,000- <$25,000, $25,000- <$35,000, $35,000- <$50,000, or ≥$50,000), insurance 
status (insured or uninsured), insulin use (yes or no) and receipt of a diabetes education course 
(yes or no) (65, 68, 77, 79, 80, 101, 121, 122). 
 
Statistical Analysis 
 Descriptive statistics for all outcome, exposure and potential confounder variables were 
calculated with adjustment for the complex sample design of the BRFSS to provide population 
level proportions.  Descriptive statistics were also provided for the sample stratified by receipt or 
non-receipt of the ADFSE.  Chi-squared and student’s t-test were utilized to compare groups.  
 The SEM two step approach was used to assess the simultaneous, direct effects of the 
latent variables for competing demands and the number of health care visits have on the 
performance of the ADFSE.  CFA was conducted to determine the goodness-of-fit for the 
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measurement model for the latent variable.  The latent variable indicators were: HgbA1c and 
cholesterol blood tests, retinal exams, and receipt of influenza and pneumonia vaccinations.  
Good model fit was defined by an RMSEA less than 0.05 and CFI of greater than 0.95 (113).  
Standardized solutions were calculated for factor loading estimates. Indicators with poor 
correlations (r<0.2) to the latent construct were be removed from the model.  Model fit was be 
reassessed for any trimmed model.  Unstandardized and standardized solutions were calculated 
for each indicator along with variance explained.   
 Potential confounding variables were determined by calculating the odds ratio and 95% 
CI between each potential confounder and the outcome.  The final model included confounders 
that had a significant (p<0.05) bivariate association with the outcome.  The final structural 
model, including the latent variable, number of visits for diabetes care and significant 
confounders, was assessed for goodness-of-fit.  An RMSEA of less than 0.05 and a CFI greater 
than 0.95 .  Data analyses were conducted using SAS version 9.4 (SAS Institute Inc., Cary, NC, 
USA) and MPlus version 9 (Muthén & Muthén, Los Angeles, CA, USA).   
 
RESULTS 
 Table 1 presents the descriptive statistics for the total population and stratified based on 
receipt of the ADFSE.  In 2015, 80.4% of the US population received the ADFSE.  The sample 
was 51.0% male, 57.4% under the age of 65 and 62.7% non-Hispanic white.  A majority of the 
population reported having at least some college education (54.0%), were married or in a 
member of an unmarried couple (62.5%) and reported an annual household income over $35,000 
(52.5%).  Over 95% of the population had some form of health insurance, only 34.5% reported  
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Table 5-1- Demographic characteristics of persons aged ≥18 years with diagnosed diabetes, 38 states* 
(n=19,056) 
 Population 
estimate 
 
 %           SE 
Received annual diabetic foot 
screening exam in Past 12 months 
         Yes                          No      
      80.4±0.9%†           19.6±0.9%†         
     %           SE           %             SE            
P value‡ Bivariate 
analysis 
Odds ratio 
(95% CI) 
DEMOGRAPHIC CHARACTERISTICS 
Sex 
   Male 
   Female 
 
51.0 
49.0 
 
1.1 
1.1 
 
51.6 
48.4 
 
1.2 
1.2 
 
51.6 
48.4 
 
2.4 
2.4 
 
0.2357 
 
1.14 (0.92-1.41) 
Age (years) 
   18-64 
   ≥65 
 
57.4 
42.2 
 
1.0 
1.0 
 
56.9 
43.1 
 
1.2 
1.2 
 
61.7 
38.3 
 
2.4 
2.4 
 
0.0763 
 
0.82 (0.66-1.02) 
Race 
   Non-Hispanic white 
   Non-Hispanic black 
   Hispanic 
   Other 
 
62.7 
15.0 
14.3 
8.0 
 
1.2 
0.7 
1.0 
1.0 
 
63.2 
16.1 
12.8 
7.8 
 
1.3 
0.8 
1.1 
1.1 
 
60.3 
10.6 
20.4 
8.6 
 
2.7 
1.2 
2.9 
1.7 
 
0.0029 
 
ref 
0.69 (0.53-0.90) 
1.67 (1.11-2.50) 
1.16 (0.69-1.94) 
Education 
   Less than high school 
   High school graduate 
   Some college 
   College graduate 
 
16.0 
30.3 
32.9 
21.1 
 
0.9 
0.9 
1.0 
0.9 
 
16.0 
30.0 
33.2 
20.8 
 
1.0 
1.0 
1.1 
1.0 
 
16.0 
31.7 
30.1 
22.1 
 
2.2 
2.3 
2.0 
1.9 
 
0.7040 
 
0.94 (0.63-1.41) 
1.00 (0.75-1.33) 
0.86 (0.66-1.12) 
ref 
Marital status 
   Married/couple 
   Divorced/separated 
   Widowed 
   Never married 
 
62.5 
16.5 
12.2 
8.9 
 
0.9 
0.6 
0.5 
0.5 
 
62.7 
16.1 
12.2 
8.9 
 
1.0 
0.6 
0.6 
0.6 
 
61.4 
18.0 
11.9 
8.7 
 
2.2 
1.5 
1.1 
1.1 
 
0.7042 
 
ref 
1.14 (0.89-1.46) 
1.00 (0.78-1.27) 
0.99 (0.72-1.37) 
Annual Household 
Income 
   <$15,000 
   $15,000-<$25,000 
   $25,000-<$35,000 
   $35,000-<$50,000 
    ≥$50,000 
 
 
14.2 
21.3 
12.1 
13.7 
38.8 
 
 
0.8 
0.8 
0.6 
0.6 
1.1 
 
 
13.8 
21.3 
11.7 
13.7 
39.6 
 
 
0.9 
0.9 
0.7 
0.6 
2.2 
 
 
16.0 
21.2 
13.5 
13.7 
35.5 
 
 
2.2 
2.1 
1.7 
1.4 
2.2 
 
 
0.4751 
 
 
1.30 (0.89-1.89) 
1.11 (0.83-1.49) 
1.29 (0.92-1.80) 
1.11 (0.84-1.48) 
ref 
Health insurance 
   Yes 
   No 
 
95.1 
4.9 
 
0.5 
0.5 
 
95.3 
4.7 
 
0.6 
0.6 
 
94.1 
5.9 
 
1.0 
1.0 
 
0.2613 
 
ref 
1.28 (0.83-2.00) 
Use insulin 
   Yes 
   No 
 
34.5 
65.5 
 
1.0 
1.0 
 
37.2 
62.8 
 
1.1 
1.1 
 
23.3 
76.7 
 
2.0 
2.0 
 
<0.0001 
 
ref 
1.95 (1.54-2.48) 
Received diabetes 
mellitus education 
   Yes 
   No 
 
 
60.3 
39.7 
 
 
1.0 
1.0 
 
 
63.0 
37.0 
 
 
1.1 
1.1 
 
 
48.9 
51.1 
 
 
2.4 
2.4 
 
 
<0.0001 
 
 
ref 
1.78 (1.44-2.21) 
* The 38 states include: In 2015, the 38 states that participated in the Diabetes Mellitus Optional Module included: 
Arizona, California, Colorado, Connecticut, Delaware, District of Columbia, Florida, Georgia, Hawaii, Illinois, 
Indiana, Iowa, Kansas, Kentucky, Louisiana, Maryland, Michigan, Minnesota, Montana, Nebraska, Nevada, New 
Hampshire, New Jersey, New Mexico, New York, North Carolina, Oklahoma, Pennsylvania, Rhode Island, South 
Carolina, Tennessee, Texas, Vermont, Utah, Virginia, Washington, Wisconsin, Wyoming.   † Percentage of 
population ± SE. ‡ P-values from χ2 test.   
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using insulin for management of diabetes, and 60.3% report having received formal diabetes 
mellitus education.   
 Examining the study population who received the ADFSE in 2015, 51.6% were male and 
56.9% were under the age of 65.  Race was distributed as follows: 63.2% non-Hispanic white, 
16.1% non-Hispanic black, 12.8% Hispanic and 7.8% reported other races.  A majority of the 
population who received the ADFSE had at least some college level education (54.0%), were 
married or a member of an unmarried couple (62.7%) and reported over $35,000 in annual 
household income (53.5%).  Ninety-five and half percent (95.5%) reported having some form of 
health insurance, 37.2% used insulin and 63.0% received formal diabetes education and also 
received the ADFSE in 2015.   
 Among the population that did not receive the ADFSE, 51.6% were male, 61.7% were 
under the age of 65.  Exploration of the distribution of race in those who did not receive the 
ADFSE 60.3% were non-Hispanic white, 10.6% were non-Hispanic black, 20.4% were Hispanic 
and 8.6% reported another race.  Similar to the population that received the ADFSE, of those 
who were not 52.2% were married or a member of an unmarried couple, 49.2% reported an 
annual household income over $35,000 and 94.1% reported having health insurance.  However, 
only 23.3% who used insulin and 48.9% who received formal diabetes education did not receive 
the ADFSE.  
 Table 2 displays the proportion of the total population, and the population stratified by 
ADFSE receipt in 2015, who reported completion of the 5 diabetes preventive care processes.  
On average, the population received 3.9 of the preventive care practices and had an average of 
4.0 visits to a health care provider for diabetes care in the past 12 months.  In the population 
overall, 81.4% received at least 2 HgbA1c tests in the past 12 months and 98.4% received a 
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cholesterol blood test in the past 2 years.  Comprehensive visions exams were completed by 
88.7% of the study population in the past 12 months.  Vaccine receipt was not completed at 
similar rates of the other preventive care processes.  In 2015, 59.5% received an influenza 
vaccine in the past 12 months and 64.4% have ever received the pneumococcal vaccine.   
Table 5-2- Reported completion of diabetes preventive care processes in persons aged ≥18 years with 
diagnosed diabetes, 38 states* (n=19,056) 
 Population estimate 
 
%                SE 
Received annual diabetes foot screening 
exam in past 12 months 
              Yes                                 No      
           80.4±0.9%†                  19.6±0.9%†              
      %                SE                %                SE            
P value† 
At least 2 HgbA1c tests in 
past 12 months 
   Yes 
   No 
 
 
81.4 
18.6 
 
 
0.8 
0.8 
 
 
83.4 
16.6 
 
 
0.9 
0.9 
 
 
73.0 
27.0 
 
 
1.9 
1.9 
 
<0.0001 
Cholesterol blood test in 
past 2 years 
   Yes 
   No 
 
 
98.4 
1.6 
 
 
0.4 
0.4 
 
 
98.5 
1.5 
 
 
0.5 
0.5 
 
 
97.9 
2.1 
 
 
0.5 
0.5 
 
 
0.3336 
Comprehensive vision exam 
in last 12 months 
   Yes 
   No 
 
 
88.7 
11.3 
 
 
0.6 
0.6 
 
 
90.9 
9.1 
 
 
0.6 
0.6 
 
 
80.0 
20.0 
 
 
1.9 
1.9 
 
 
<0.0001 
Received influenza vaccine 
in past 12 months 
   Yes 
   No 
 
 
59.5 
40.5 
 
 
1.1 
1.1 
 
 
60.6 
39.5 
 
 
1.2 
1.2 
 
 
54.9 
45.1 
 
 
2.4 
2.4 
 
 
0.0314 
Ever receive pneumococcal 
vaccine 
   Yes 
   No 
 
 
64.4 
35.6 
 
 
1.1 
1.1 
 
 
67.2 
32.8 
 
 
1.2 
1.2 
 
 
52.9 
47.1 
 
 
2.4 
2.4 
 
 
<0.0001 
 
 Population Mean 
  Mean             SE 
Received annual diabetes foot screening 
exam in past 12 months 
              Yes                                 No      
      
  Mean             SE             Mean             SE 
P value‡ 
Visits for diabetes care 3.95 0.13 4.09 0.15 3.41 0.15 <0.0001 
Number of diabetes 
preventive care processes 
completed 
 
3.92 
 
0.01 
 
4.01 
 
0.03 
 
3.59 
 
0.05 
 
<0.0001 
* The 38 states include: In 2015, the 38 states that participated in the Diabetes Mellitus Optional Module 
included: Arizona, California, Colorado, Connecticut, Delaware, District of Columbia, Florida, Georgia, Hawaii, 
Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maryland, Michigan, Minnesota, Montana, Nebraska, 
Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, Oklahoma, Pennsylvania, 
Rhode Island, South Carolina, Tennessee, Texas, Vermont, Utah, Virginia, Washington, Wisconsin, Wyoming.   
† Percentage of population ± SE. ‡ P-values from χ2 test.   
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 When the population was stratified, the group who received the ADFSE receive an 
average of 4.0 diabetes preventive care processes and reported an average of 4.1 visit to a 
healthcare provider for diabetes care.  Of this population, 83.4% received the recommend 
number of HgbA1c tests, 98.5% received a cholesterol blood test in the last 2 years and 90.9% 
received a comprehensive vision exam in the past year.  Finally, 60.6% received the influenza 
vaccine in the past 12 months and 67.2% have receipted a pneumococcal vaccine as well are 
receiving the ADFSE in 2015.   
 The population who did not receive the ADFSE reported receiving an average of 3.6 
diabetes preventive care processes and attended an average of 3.4 visits to a healthcare provider 
for diabetes care.  This group reported receipt of diabetes care processes as: 73.0% had 2 
HgbA1c tests in the past 12 months, 97.9% have had a cholesterol blood test in the past 2 years, 
80.0% have had a comprehensive vision exam in the last 12 months, 54.9% reported receipt of 
the influenza vaccine in the past 12 months and 52.9% have received the pneumococcal vaccine.  
The fit statistics for the CFA model were: χ2 (df=5)=18.133, p=0.0028, RMSEA=0.01 
(90%CI: 0.006-0.018), CFI=0.95.  The RMSEA and CFI statistics indicate the measurement 
model is a good fit of the data.    Table 3 presents the unstandardized coefficients, standardized 
coefficients and the percentage of variance the latent variable explains for each indicator.  The 
latent variable for competing demands explains over 56% of the variance for the indicator for 
receipt of a comprehensive vision exam in the past 2 years.  However, the latent variable only 
explains 21% of the variance for the indicator for receipt of 2 HgbA1c blood tests in the past 12 
months. 
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Table 5-3- Final CFA model unstandardized coefficients, standardized coefficients and percentage of 
variance explained for each indicator.  RMSEA=0.01.  CFI=0.95   
Indicator Latent variable Unstandardized 
coefficient (B) 
Standardized 
coefficient (β) 
Percentage of 
variance explained 
for the indicator 
At least 2 HgbA1c 
tests in past 12 
months 
Competing 
demands 
1.00 0.46±0.04 21.2% 
Cholesterol blood test 
in past 2 years 
Competing 
demands 
1.42±0.26 0.65±0.12 42.3% 
Comprehensive 
vision exam in last 12 
months 
Competing 
demands 
0.75±0.14 0.34±0.05 56.3% 
Received influenza 
vaccine in past 12 
months 
Competing 
demands 
1.08±0.14 0.49±0.05 24.0% 
Ever receive 
pneumococcal 
vaccine 
Competing 
demands 
1.51±0.18 0.69±0.05 47.6% 
 
Figure 1 presents the results of the full SEM model including odds ratios (OR), 95%CI 
and p values for each of the paths.  The full SEM model fit statistics were: χ2 (df=21)=268.654, 
p<0.0001, RMSEA=0.018 (90%CI: 0.016-0.021), CFI=0.832.  The null model RMSEA was 
found to be 0.038 and indicates the CFI may not be ideal to measure the fit of this model (113).  
There was a significant association (P<0.001) between the competing demands latent variable 
and performance of the ADFSE.  For every unit increase in competing demands, there was a 7% 
(OR: 1.07, 95%CI: 1.05-1.10, p<0.0001) increase in the likelihood the ADFSE was performed.  
No significant association was present between the number of visits for diabetes care and the 
performance of the ADFSE (OR=1.00, 95%CI=1.00-1.00, p=0.56).   
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  Figure 5-1- Final SEM model.  RMSEA=0.036.  
  
  Solid pathways indicate statistically significant model pathways.  Dashed pathways indicate non-significant   
  pathways.  ADFSE- annual diabetes foot screening exam.  Flu- influenza.  PNA- pneumococcal. 
 
Table 5-4- Odds ratios (OR), 95% confidence intervals (95% CI)) and p-values for regression pathways of 
the final SEM model.   
Pathway OR  95% CI P-value 
Competing demands → ADFSE 1.07 1.05-1.10 <0.0001 
Number of visits to healthcare 
provider → ADFSE  
1.00 1.00-1.00 0.56 
Race → ADFSE 0.98 0.97-0.99 0.16 
Insulin use → ADFSE 1.07 1.05-1.09 <0.0001 
Diabetes education → ADFSE 1.07 1.05-1.09 <0.0001 
  
CONCLUSIONS 
  The results of this study found that over 80% of patients with diabetes who had at least 
one visit to a health care provider received the ADFSE.  This rate is exceeds the goal of Healthy 
People 2020, but our rate does not include those without a visit to a health provider, and may 
help contribute to lower rates of DFUs and LEAs in the future (91).  We also found a positive 
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association between the performance of an increasing number of other diabetes preventive care 
process, often defined as improved quality of care, and the performance of the ADFSE.  Our 
results suggest that completion of multiple preventive care processes recommended for patients 
with diabetes is not competing with the performance of the ADFSE but rather improves 
performance of the ADFSE.  Unlike prior research, our study did not find a significant 
association between the number of visits to a health care provider for diabetes care and the 
performance of the ADFSE.   
 Recent changes in the payments systems in and the structure of the US healthcare 
systems may help explain our finding of the positive association between improved diabetes 
quality of care and the performance of the ADFSE.  Incentive programs by CMS to implement 
meaningful use of electronic medical records (EMR), including development of chronic disease 
registries, began in the US in 2011 (123).  Since that time research has demonstrated that the use 
of a diabetes registry in clinical practice improved rates of completion of diabetes preventive 
care processes and reduced hospital utilization in this patient population.  A systematic literature 
review found that the utilization of clinical decision support systems within EMR also 
demonstrated improvements in the quality of care provided to patients with diabetes (124).  CMS 
has also provided 1.5% Medicare payment bonuses to providers who participated in the 
Physician Quality Reporting System (PQRS) from 2007 through 2015 (125).  The PQRS system 
included a Diabetes Measure which included addressing HgbA1c control, influenza vaccine, 
vision exams, management of nephropathy, exam for PN and smoking cessation interventions at 
specified intervals of patient visits (106).  Participation in the PQRS system was associated with 
improvements in the provision of the ADFSE along with other quality of care measures in 
patients with diabetes (126).  The use of inventive payments to improve diabetes quality of care 
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is one likely explanation for our positive finding between the performance of diabetes preventive 
care processes and the performance of the ADFSE.   
 The introduction of patient centered medical home (PCMH) model into the US healthcare 
system may also explain the positive association between completion of increasing numbers of 
diabetes preventive care processes and the performance of the ADFSE (127).  PCMHs strive to 
provide accessible, patient-centered, coordinated and comprehensive clinical care.  Data 
collected by the MEPS, a nationally representative survey, revealed patients who belong to a 
PCMH had higher rates of completion of ADA recommended diabetes preventive care processes 
compared to those patient who did not belong to a PCMH (118).  The VHA has also 
implemented the PCMH model and demonstrated improvements diabetes quality of care (128).  
Specifically, the ADFSE completion rates have increased.  In 2013, nearly 20% of US primary 
providers reporting belonging to a PCMH model (129). 
 This study has many strengths including being the first study, to our knowledge, to 
explore the simultaneous association between competing demands of diabetes care and the 
number of visits for diabetes care.  Our study also utilized a large, national data set which 
provided results that are generalizable to the US population with diabetes.  In addition, the 
BRFSS is also used to inform Healthy People 2020 which increases the external validity of our 
results (62).  The main outcome of our study, self-report of the ADFSE, has been validated in 
prior studies, which reduces the risk of misclassification bias in our results (43, 103).   
 Despite these strengths, our study has several limitations.  The self-report nature of the 
BRFSS data may introduce recall and social desirability bias into our results while the cross 
sectional design limited determination of causality.  Another major limitation is the inability to 
differentiate patients with type 1 diabetes and type 2 diabetes in the study sample.  Given the 
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differences in disease management, prioritization of preventive care processes, and the 
management of other comorbidities, the joint analysis of both populations may cancel out a 
difference in effect (4).  In addition, the BRFSS does not have information on the number of 
visits respondents make to other health care providers for management of medical issues other 
than diabetes.  Diabetes specific preventive care processes may have been completed in these 
visits but not accounted for in our analysis. 
 In conclusion our study sought to explore the relationship between competing demands 
and the number of visits for diabetes care and the performance of the ADFSE.  Improving overall 
diabetes quality of care can potentially improve the rates of ADFSE completion.  Thus programs 
to aid health care providers in completion of diabetes preventive care processes, such as use of 
EMR, financial incentives to complete preventive screenings and the PCMH model, should be 
further explored to determine their effect on increasing the rates of the ADFSE and ultimately, 
the reduction of DFUs and LEAs.  While the benefit of ADFSE on the prevention of these life 
threatening complications are well known, efforts must be made to increase their application in 
the US clinical care environment.  Reports from 2017 estimate that between 1.0 million to 3.5 
million people in the US have had a DFU at some point in their lifetime and more than 100,000 
underwent an LEA (8, 23).  These numbers can only be reduced with provision of evidence-
based screening and prevention practices.   
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CHAPTER 6: Summary 
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SUMMARY 
  DFUs and LEAs continue to be a major public health problem and result in decreased 
quality of life for patients and high costs of care for the US healthcare system (8, 15, 24, 130).  
Rates of DFUs and LEAs can be reduced through comprehensive screening and prevention 
programs (32, 33).  The ADA and the IWGDF recommend patients with diabetes receive a 
comprehensive diabetic foot exam at least once a year (33-35). However, population estimates 
from 2012 demonstrated that only 71% of the US population received the ADFSE (38).  Clinical 
reports of completion of the ADFSE vary from 12% to 95% (39-46).  Prior research has 
identified age, race, gender, education, insurance and rural residency are factors that are 
associated with the performance of the ADFSE (47-49).  However, little research has explored 
the association between clinically meaningful factors and the performance of the ADFSE.  The 
aim of this dissertation was to examine the associations between clinically meaningful factors 
and the performance of the ADFSE.  The Piette and Kerr conceptual framework on competing 
demands of chronic comorbid conditions in diabetes care was utilized to guide the analyses (50).  
Our studies found between 78.2% and 80.4% of patient with diabetes, who had at least one visit 
to a healthcare provider for diabetes care, received the ADFSE in 2015.   
 Chapter 3, titled “Are diabetes mellitus self-management behaviors associated with the 
receipt of the recommended annual diabetes foot screening examination?” examined the 
relationship between 8 individual diabetes self-management behaviors and the performance of 
the ADFSE.  The eight diabetes self-management behaviors included: performing SMBG at least 
one time per day, performing a self-foot inspection at least one time per day, receipt of the 
influenza vaccine in the past 12 months, receipt of the pneumococcal vaccine at any time, 
meeting aerobic and resistance training exercise recommendations, smoking status and alcohol 
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consumption.  Logistic regression models were used to assess the association between an 
individual self-management behavior and the receipt of the ADFSE.  One-way interactions with 
insulin use status and receipt of formal diabetes education were also examined to determine if 
these variables modified the association between a self-management behavior and performance 
of the ADFSE.  Insulin use was found to modify the association between receipt of the influenza 
vaccine, performance of the recommended dosage of aerobic exercise and avoidance of 
excessive alcohol consumption.  However, the receipt of the influenza vaccine and the 
performance of the recommended dosage of aerobic exercise did not demonstrate significant 
associations with the performance of the ADFSE when the effect modification by insulin use was 
considered.  Among those who do not use insulin and do consume an excessive amount of 
alcohol there is more than 3 times increased odds ADFSE is performed compared to those who 
do not use insulin and avoid excessive alcohol usage.  Both status of insulin use and of the 
receipt of formal diabetes education were found to be significant effect modifiers of the 
relationship between performance of SMBG at least one time per day and the receipt of the 
ADFSE.  Among the groups who do not use insulin and did and did not receive formal diabetes 
education, those who do not perform SMBG at least one time per day were over 48% less likely 
to receive the ADFSE compared to counterparts who did perform the recommended self-
management behavior.  These results suggest that patient education programs which educate 
patients on and encourage performance of self-management behaviors may help improve the 
rates of performance of the ADFSE in the US population with diabetes.   
 Chapter 4, entitled “The association between comorbidities and the performance of the 
recommended annual diabetic foot screening examination” examined the simultaneous, direct 
effects of concordant and discordant comorbidities on the performance of the ADFSE.  SEM 
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methods were employed to simulate clinical decision making which allows for consideration of 
multiple types of information to be considered in parallel.  No significant simultaneous, direct 
associations between concordant nor discordant medical comorbidities and the performance of 
the ADFSE were found.  These results may indicate that decisions about performance of the 
ADFSE are not influenced by patients’ comorbidity profiles.  They may also be a reflection of 
changing payment models and quality reporting requirements which been implemented over the 
past decade within the US healthcare system.    
 The last chapter, Chapter 5, titled “The associations between visit frequency and 
competing demands on the performance of recommended annual clinical diabetic foot screening” 
examined the associations between the performance of other diabetes preventive care processes, 
the number of office visits for diabetes care and the completion of the ADFSE.  SEM method 
were utilized to explore these associations simultaneously.  The number of visits to a healthcare 
provider for diabetes care was found to have a non-significant association with the ADFSE in 
our model.  The model demonstrated a positive association between the performance of an 
increasing number of other diabetes preventive care process, often defined as improved quality 
of care, and the performance of the ADFSE.  Our results suggest that completion of multiple 
preventive care processes recommended for patients with diabetes is not competing with the 
performance of the ADFSE but rather improves performance of the ADFSE.  These results 
suggest that programs which encourage healthcare providers to improve overall quality of care to 
patients with diabetes may be one way to improve the performance of the ADFSE.  
Implementation of patient programs to increase patient activation and participation in their own 
care, and empowering patients to request providers perform all recommended preventive care, 
may also help improve the performance of the ADFSE.   
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IMPLICATIONS FOR PUBLIC HEALTH 
 Diabetes is predicted to affect more than one-quart of the US population by 2050 (3).    
By this time, as many as 44 million US residents will develop a DFU in their lifetime (3, 23, 
131).  Given the poor quality of life and high cost of care with a DFU, immediate action is 
needed to reduce the rates of DFUs and LEAs in those with diabetes (15, 130, 132).  While 
recent population level intervention to improve overall diabetes care in the US have made 
headway, further work is required to ensure the problems of the diabetic foot are also addressed 
(133). 
 First, public awareness of the complication of the diabetic foot, DFUs and LEAs needs to 
increase in the US.  While November is “National Diabetes Awareness Month”, The Save a Leg, 
Save a Life Foundation began the “White Sock Campaign” in 2013 (134, 135).  The “White 
Sock Campaign” was designed to raise awareness of the complications of diabetes and PAD.  At 
this time the campaign needs to extend beyond the walls of medical buildings and into the public 
domain to increase awareness of patients, family members, and caregivers of those with diabetes.  
National education programs, such as those successfully used in research studies, designed to 
increase patient and caregiver awareness of the diabetes foot and provide strategies to help 
reduce the risk of DFUs are also necessary to empower the population to combat this growing 
public health problem (31, 32). 
 Second, all healthcare providers should be trained and encouraged to administer the 
ADFSE during every patient interaction, or at regular intervals during periods of care.  The exam 
can be performed by a variety of healthcare providers such as physician podiatrists, nurses, 
physical therapists and pharmacists (37).  The exam requires less than 5 minutes to complete and 
is low cost, requiring only a 3.06 Semmes-Weinstein monofilament.  With more healthcare 
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providers performing the ADFSE, more patients at risk for DFU development can be identified 
and referred to appropriate prevention and treatment programs.  However, the number of these 
programs remains suboptimal in the US, and internationally, due to lack of time in the clinical 
setting, inconsistent healthcare provider training and reimbursement concerns (136).  Policy 
makers and health insurance providers will need to make DFU prevention a priority and 
implement changes to support healthcare providers and provide patients with evidence based 
care.     
 
FUTURE RESEARCH 
 Future research is necessary to ensure that 100% of the US population with diabetes 
receives the ADFSE.  While this dissertation found positive associations between the ADFSE 
and various clinically relevant factors, the cross-sectional nature of the data precludes the ability 
to determine causality.  Longitudinal data, from EMRs, national registries or prospective studies, 
will be required to explore whether diabetes self-management behavior and performance of other 
diabetes preventive care processes lead directly to improved rates of performance of the ADFSE.   
 Additional studies on these topics will also benefit from exploring T1DM and T2DM 
populations separately and provider type (eg- general practice vs. endocrinology).  Given the 
differences in disease etiology, age of onset differences, and differences in health care service 
utilization it will be important for future studies to ensure each patient group receives appropriate 
research consideration (4, 137).  Prior research has also identified provider type can influence the 
performance of preventive health services (77, 100-102, 137).  Specific to diabetes preventive 
care, endocrinologists were more likely to administer HgbA1c test and retinal exams compared 
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to primary care physicians (100).  Prioritization of the multiple recommended diabetes 
preventive care processes also differs by provider type (77). 
 Exploration of the effect modification by status of insulin use and diabetes education is 
also required in future research.  It is possible that some portion of the effect modification by 
insulin use, found in this dissertation, may be due to the differences in the management of T1DM 
and T2DM mentioned previously (4).  These effect modifications may also be explained by other 
physiologic measures, such as HgbA1c level, blood cholesterol levels or blood pressure that are 
used to determine relative control of diabetes and associated comorbidities (120).  The effect 
modification based on receipt of diabetes education which was observed in this dissertation 
should also be further explored.  One prior study has demonstrated that while diabetes education 
and knowledge improve patient performance of self-management behaviors, it does not have an 
association with completion of preventive care nor control of metabolic measures (94).  It is 
possible that diabetes education is a proxy for a yet unexplored variable that may explain group 
differences.  Finally, while not explored in this dissertation, future research will also need to 
determine if effect modification by status of insulin use or formal diabetes education, exists 
when other pathways of the Piette and Kerr model are examined (50).     
 Ultimately, future research will also need to firmly establish if the positive findings of 
this dissertation will reduce the rates of DFUs and LEAs in the US.   DFU and LEA rate 
reductions have resulted from comprehensive programs that began with the ADFSE and then 
provided appropriate interventions and follow up (31, 32, 138-142).  Margolis, et al. utilized the 
BRFSS and demonstrated a negative association between receipt of colorectal cancer screening 
and LEAs suggesting that receipt of preventive care processes may reduce LEAs (92).  However, 
this study did not find any significant associations between the examined diabetes self-
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management behaviors, some of which were explored in this study, and LEAs.  Regardless, a 
causal link must be established between diabetes self-management behaviors and the 
performance of other diabetes preventive care processes, the ADFSE and reduction in rates of 
DFUs and LEAs to ensure early interventions at the prevention level will result in a positive 
outcomes on quality of life for patients with diabetes and reduce the burden on the healthcare 
system.   
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